19012002 | Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women with breast cancer: clinical and immunohistochemical correlates. | Med Oncol | 2009 | Loredo-Pozos G | doi: 10.1007/s12032-008-9114-7 |
28900739 | A frameshift mutation in BRCA1 leads to hereditary breast and ovarian cancer in one part of a family and to familial pancreatic cancer in another. | Breast Cancer Res Treat | 2018 Jan | Gieldon L | doi: 10.1007/s10549-017-4500-5 |
26392358 | Methylation biomarkers for pleomorphic lobular breast cancer - a short report. | Cell Oncol (Dordr) | 2015 Oct | Moelans CB | doi: 10.1007/s13402-015-0241-9 |
24915755 | A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer. | BMC Cancer | 2014 Jun 10 | Dorairaj JJ | doi: 10.1186/1471-2407-14-421. |
21781528 | [The correlation between chemotherapeutic efficacy and breast cancer susceptibility gene 1 and class IIIβ-tubulin protein expression in non-small cell lung cancer patients]. | Zhonghua Nei Ke Za Zhi | 2011 Jun | Wan YY | doi: 10.3760/cma.j.issn.0578-142.2011.06.006. |
24335192 | EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1. | Cancer Biol Ther | 2014 Mar 1 | Li T | doi: 10.4161/cbt.27306 |
25319390 | miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer. | Mol Cancer Ther | 2014 Dec | Tang H | doi: 10.1158/1535-7163.MCT-14-0243 |
25132263 | BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin. | Oncogene | 2015 Jun 4 | Paul BT | doi: 10.1038/onc.2014.237 |
16543155 | A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination. | Mol Cell | 2006 Mar 17 | Brzovic PS | - |
25480944 | TUSC4 functions as a tumor suppressor by regulating BRCA1 stability. | Cancer Res | 2015 Jan 15 | Peng Y | doi: 10.1158/0008-5472.CAN-14-2315 |
22579790 | Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma. | Gynecol Oncol | 2012 Aug | Hyman DM | doi: 10.1016/j.ygyno.2012.05.001 |
14576434 | Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. | Science | 2003 Oct 24 | King MC | - |
23047605 | Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body production. | Cell Cycle | 2012 Nov 15 | Salem AF | doi: 10.4161/cc.22316 |
12607598 | Frequent loss of BRCA1 nuclear expression in young women with breast cancer: an immunohistochemical study from an area of low incidence but early onset. | Appl Immunohistochem Mol Morphol | 2002 Dec | Lee WY | - |
18445692 | Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. | Clin Cancer Res | 2008 May 15 | Willems AJ | doi: 10.1158/1078-0432.CCR-07-5237 |
22931600 | [BRCA1 inhibits progesterone-induced proliferation and migration of breast cancer cells]. | Nan Fang Yi Ke Da Xue Xue Bao | 2012 Aug | Xiong J | - |
16011248 | [Genetic instability on chromosome 17q21 in gastric cancer of Chinese patients]. | Shi Yan Sheng Wu Xue Bao | 2005 Apr | Lin XQ | - |
25522926 | Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer. | Hum Pathol | 2015 Feb | van Verschuer VM | doi: 10.1016/j.humpath.2014.10.020 |
24935384 | No association between BRCA1 immunohistochemical expression and tumor grade, stage or overall survival in platinum-treated epithelial ovarian cancer patients. | Asian Pac J Cancer Prev | 2014 | Shawky Ael-A | - |
16945238 | Medullary carcinoma of breast with a novel germline mutation 1123T >G in exon 11 of BRCA1. | J Coll Physicians Surg Pak | 2006 Sep | Moattar T | - |
18045956 | Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. | Endocr Relat Cancer | 2007 Dec | Hudelist G | - |
27008870 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. | Hum Mol Genet | 2016 Jun 1 | de la Hoya M | - |
28358361 | Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines. | Cell Death Dis | 2017 Mar 30 | Karanam NK | doi: 10.1038/cddis.2017.136. |
29712865 | Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1. | Proc Natl Acad Sci U S A | 2018 May 15 | Seo A | doi: 10.1073/pnas.1801796115 |
29970689 | Extent of breast cancer type 1 promoter methylation correlates with clinicopathological features in breast cancers. | J Cancer Res Ther | 2018 Jun | Sun MY | doi: 10.4103/0973-1482.235354. |
30733286 | AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer. | Proc Natl Acad Sci U S A | 2019 Feb 26 | Kubli SP | doi: 10.1073/pnas.1815126116 |
26048987 | Deciphering the BRCA1 Tumor Suppressor Network. | J Biol Chem | 2015 Jul 17 | Jiang Q | doi: 10.1074/jbc.R115.667931 |
20389018 | HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. | J Clin Invest | 2010 May | Gilbert PM | doi: 10.1172/JCI39534 |
25496700 | Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer. | J Transl Med | 2014 Dec 14 | Shen J | doi: 10.1186/s12967-014-0355-2. |
28376175 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. | J Natl Cancer Inst | 2017 Jul 1 | Kuchenbaecker KB | doi: 10.1093/jnci/djw302. |
20845286 | Induction of breast cancer in wild type p53 cells by BRCA1-IRIS overexpression. | Hawaii Med J | 2010 Aug | Elshamy WM | - |
27249681 | Women's Health Issues for BRCA Mutation Carriers. | Am Soc Clin Oncol Educ Book | 2016 | Sabatini ME | doi: 10.14694/EDBK_100001. |
28364669 | Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea. | Breast | 2017 Jun | Ryu JM | doi: 10.1016/j.breast.2017.03.006 |
16772120 | Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. | Cancer Genet Cytogenet | 2006 Jul 1 | Preisler-Adams S | - |
26588056 | Risk-reducing surgery in BRCA 1/2 mutation carries: a point of view. | Oncotarget | 2015 Nov 24 | De Felice F | doi: 10.18632/oncotarget.6348. |
26989051 | Male breast cancer is not congruent with the female disease. | Crit Rev Oncol Hematol | 2016 May | Fentiman IS | doi: 10.1016/j.critrevonc.2016.02.017 |
26414677 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. | Nat Genet | 2015 Nov | Day FR | doi: 10.1038/ng.3412 |
12096901 | Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1. | J Mol Biol | 2002 Jul 12 | Ekblad CM | - |
12509456 | Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus. | Mol Cell Biol | 2003 Jan | Miralem T | - |
26715507 | Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis. | BMC Cancer | 2015 Dec 29 | Romagnolo DF | doi: 10.1186/s12885-015-2044-9. |
27003155 | NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial. | Virchows Arch | 2016 Jun | Endris V | doi: 10.1007/s00428-016-1919-8 |
20032382 | Aneuploidy is associated with TP53 expression but not with BRCA1 or TERT expression in sporadic colorectal cancer. | Anticancer Res | 2009 Nov | Schjlberg AR | - |
19120025 | Cloning and functional identification of two novel BRCA1 splicing variants. | Biochemistry (Mosc) | 2008 Nov | Miao L | - |
21946536 | Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. | Nat Med | 2011 Sep 25 | Chang S | doi: 10.1038/nm.2459. |
17307836 | Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. | J Med Genet | 2007 Jul | Kadouri L | - |
24168967 | miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition. | J Natl Cancer Inst | 2013 Nov 20 | Sun C | doi: 10.1093/jnci/djt302 |
23155271 | Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer. | Anticancer Res | 2012 Nov | Pesta M | - |
26745875 | BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing. | Oncotarget | 2016 Jan 12 | Mafficini A | doi: 10.18632/oncotarget.6834. |
16843262 | Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature. | Cancer Cell | 2006 Jul | Furuta S | - |
17505536 | Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. | Int J Biol Sci | 2007 Apr 25 | Hoshino A | - |
16326698 | BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. | J Biol Chem | 2006 Feb 10 | Moreau K | - |
20581465 | BRCA1 regulation of base excision repair pathway. | Cell Cycle | 2010 Jul 1 | Saha T | doi: 10.4161/cc.9.13.12084. |
24675954 | Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. | Science | 2014 Mar 28 | Venkitaraman AR | doi: 10.1126/science.1252230. |
22382806 | Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. | Breast Cancer Res Treat | 2012 Jun | Son BH | doi: 10.1007/s10549-012-2001-0 |
16782705 | BRCA1 interacts with poly(A)-binding protein: implication of BRCA1 in translation regulation. | J Biol Chem | 2006 Aug 25 | Dizin E | - |
15665273 | Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2. | Cancer Res | 2005 Jan 1 | Hayami R | - |
17000754 | Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. | Mol Cell Biol | 2006 Dec | Bartz SR | - |
26227317 | Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer. | Mol Cancer Res | 2015 Nov | Labanca E | doi: 10.1158/1541-7786.MCR-15-0150-T |
22392482 | Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ. | Apoptosis | 2012 Jul | Warrener P | doi: 10.1007/s10495-012-0707-4. |
25216750 | ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells. | Mol Cancer | 2014 Sep 12 | Leccia F | doi: 10.1186/1476-4598-13-213. |
17921118 | Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer? | Eur J Histochem | 2007 Jul-Sep | Troudi W | - |
20890790 | [Genes beyond BRCA1 and BRCA2 for hereditary breast cancer]. | Wien Med Wochenschr | 2010 Nov | Simon K | doi: 10.1007/s10354-010-0831-0. |
12086871 | The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. | Cancer Cell | 2002 Mar | Elledge SJ | - |
25884417 | BRCA1 Alternative splicing landscape in breast tissue samples. | BMC Cancer | 2015 Apr 3 | Romero A | doi: 10.1186/s12885-015-1145-9. |
16969499 | Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo. | Oncol Rep | 2006 Oct | Quaresima B | - |
23567481 | Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients. | Eur J Radiol | 2013 Sep | Mann RM | doi: 10.1016/j.ejrad.2013.03.003 |
22172724 | BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance. | Cancer Cell | 2011 Dec 13 | Drost R | doi: 10.1016/j.ccr.2011.11.014. |
21729660 | Development of breast cancer in a 21-year-old childhood Wilms' tumor survivor with a BRCA1 2634delC mutation. | Clin Breast Cancer | 2011 Aug | Dulude AM | doi: 10.1016/j.clbc.2010.11.001 |
23674270 | BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study. | Genet Epidemiol | 2013 Jul | Ricks-Santi LJ | doi: 10.1002/gepi.21730 |
23047606 | Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NF??B activation in the tumor stroma. | Cell Cycle | 2012 Nov 15 | Martinez-Outschoorn UE | doi: 10.4161/cc.22226 |
15009718 | Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression. | J Invest Dermatol | 2004 Feb | Hesling C | - |
18683754 | [Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells]. | Zhonghua Fu Chan Ke Za Zhi | 2008 Feb | Liu GY | - |
16940470 | Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells. | Am J Physiol Endocrinol Metab | 2007 Jan | Ghosh S | - |
21344391 | Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins. | J Cell Physiol | 2011 Dec | Qin Y | doi: 10.1002/jcp.22695. |
25460500 | Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells. | Oncotarget | 2014 Dec 15 | Pickholtz I | - |
23860775 | MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency. | Tumour Biol | 2013 Dec | Ren J | doi: 10.1007/s13277-013-0983-9 |
20103620 | Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination. | Cancer Res | 2010 Feb 1 | Ransburgh DJ | doi: 10.1158/0008-5472.CAN-09-2850 |
18703154 | Interaction of p14ARF with Brca1 in cancer cell lines and primary breast cancer. | Cell Biol Int | 2008 Oct | He L | doi: 10.1016/j.cellbi.2008.07.018 |
21099359 | BRCA1 modulates the expression of hnRNPA2B1 and KHSRP. | Cell Cycle | 2010 Dec 1 | Santarosa M | - |
22401979 | Allelic transcripts dosage effect in morphologically normal ovarian cells from heterozygous carriers of a BRCA1/2 French Canadian founder mutation. | Cancer Prev Res (Phila) | 2012 May | Abd-Rabbo D | doi: 10.1158/1940-6207.CAPR-11-0547 |
21194536 | Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis. | J Theor Biol | 2011 Mar 21 | De Vargas Roditi L | doi: 10.1016/j.jtbi.2010.12.033 |
15220350 | Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1. | J Biol Chem | 2004 Aug 13 | Xu X | - |
21670155 | Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. | Mol Cell Biol | 2011 Aug | Lu Y | doi: 10.1128/MCB.01121-10 |
15166217 | Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. | J Biol Chem | 2004 Aug 6 | Choudhury AD | - |
25879355 | Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer. | J Cancer Res Ther | 2015 Jan-Mar | Hedau S | doi: 10.4103/0973-1482.140985. |
21203981 | The role of BRCA1 in DNA damage response. | Protein Cell | 2010 Feb | Wu J | doi: 10.1007/s13238-010-0010-5. |
20398395 | Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls. | BMC Cancer | 2010 Apr 16 | Heerma van Voss MR | doi: 10.1186/1471-2407-10-145. |
19649554 | Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? | Ann Surg Oncol | 2009 Dec | Garcia-Etienne CA | doi: 10.1245/s10434-009-0638-7. |
17452776 | 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations. | Cell Oncol | 2007 | Tommasi S | - |
26867710 | BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. | JAMA Oncol | 2016 Jun 1 | Rosenberg SM | doi: 10.1001/jamaoncol.2015.5941. |
17496925 | A role of estrogen/ERalpha signaling in BRCA1-associated tissue-specific tumor formation. | Oncogene | 2007 Nov 8 | Li W | - |
20814958 | Insights into the targeted elimination of BRCA1-defective cancer stem cells. | Med Res Rev | 2012 Sep | Somasundaram V | doi: 10.1002/med.20229 |
24151232 | BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC. | J Cell Biochem | 2014 Apr | Diao H | doi: 10.1002/jcb.24699. |
11983207 | Expression of BRCA1 and BRCA2 in different tumor cell lines with various growth status. | Clin Chim Acta | 2002 Jun | Vissac C | - |
20345474 | The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania. | Clin Genet | 2010 Oct | Elsakov P | doi: 10.1111/j.1399-0004.2010.01404.x. |
25428789 | Inherited predisposition to breast cancer among African American women. | Breast Cancer Res Treat | 2015 Jan | Churpek JE | doi: 10.1007/s10549-014-3195-0 |
22511931 | BRCA1-IRIS overexpression promotes formation of aggressive breast cancers. | PLoS One | 2012 | Shimizu Y | doi: 10.1371/journal.pone.0034102 |
22843497 | Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer. | Hum Mol Genet | 2012 Nov 1 | Hansmann T | doi: 10.1093/hmg/dds308 |
27997688 | Novel splice-switching oligonucleotide promotes BRCA1 aberrant splicing and susceptibility to PARP inhibitor action. | Int J Cancer | 2017 Apr 1 | Smith LD | doi: 10.1002/ijc.30574 |
26615718 | Functional crosstalk between DNA damage response proteins 53BP1 and BRCA1 regulates double strand break repair choice. | Radiother Oncol | 2016 May | Bakr A | doi: 10.1016/j.radonc.2015.11.001 |
27193872 | Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells. | Int J Cancer | 2016 Oct 1 | Zheng J | doi: 10.1002/ijc.30193 |
28377179 | Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers. | Cancer Lett | 2017 Jul 1 | Sokolenko AP | doi: 10.1016/j.canlet.2017.03.036 |
28549976 | BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study. | Am J Obstet Gynecol | 2017 Sep | Petrillo M | doi: 10.1016/j.ajog.2017.05.036 |
28264838 | Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention. | Cancer Prev Res (Phila) | 2017 Apr | Chiyoda T | doi: 10.1158/1940-6207.CAPR-16-0281 |
27167707 | Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases. | Cancer Med | 2016 Jul | Koczkowska M | doi: 10.1002/cam4.748 |
28857155 | Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe. | Int J Cancer | 2018 Jan 1 | Fountzilas G | doi: 10.1002/ijc.31023 |
28343309 | Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2017 Jun | Krammer J | doi: 10.1007/s10549-017-4198-4 |
27793035 | Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples. | Oncotarget | 2016 Dec 6 | Badoer C | doi: 10.18632/oncotarget.12877. |
28499366 | The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion. | BMC Cancer | 2017 May 12 | Bogan D | doi: 10.1186/s12885-017-3283-8. |
29860064 | Expression analysis of the MCPH1/BRIT1 and BRCA1 tumor suppressor genes and telomerase splice variants in epithelial ovarian cancer. | Gene | 2018 Sep 25 | Alsiary R | doi: 10.1016/j.gene.2018.05.113 |
27845331 | BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity. | Nat Commun | 2016 Nov 15 | Rasmussen RD | doi: 10.1038/ncomms13398. |
30049201 | Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer | Asian Pac J Cancer Prev | 2018 Jul 27 | Vu TL | - |
30315757 | Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G>A (p.Asp1778Asn) variant. | Clin Biochem | 2019 Jan | Minucci A | doi: 10.1016/j.clinbiochem.2018.10.004 |
28680148 | Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients. | Sci Rep | 2017 Jul 5 | Torres D | doi: 10.1038/s41598-017-05056-y. |
25948675 | BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing. | Oncologist | 2015 Jun | Mitri ZI | doi: 10.1634/theoncologist.2014-0425 |
18241344 | Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. | Breast Cancer Res | 2008 | Wright MH | doi: 10.1186/bcr1855 |
22136207 | Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma. | Thyroid | 2012 Jan | Xu L | doi: 10.1089/thy.2011.0117 |
16998791 | Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. | Int J Cancer | 2006 Dec 15 | Rashid MU | - |
24519767 | Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. | BMJ | 2014 Feb 11 | Metcalfe K | doi: 10.1136/bmj.g226. |
15936476 | [Molecular alterations in breast cancer: clinical implications and new analytical tools]. | Rev Med Interne | 2005 Jun | Gonalves A | - |
18030615 | High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. | Breast Cancer Res Treat | 2008 Oct | van der Groep P | - |
20077502 | Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families. | Hum Mutat | 2010 Mar | De Brakeleer S | doi: 10.1002/humu.21200. |
12440810 | Risk factors for ovarian cancer and early-onset breast cancer in Mongolia. | Eur J Gynaecol Oncol | 2002 | Elit L | - |
18355772 | Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. | Am J Hum Genet | 2008 Apr | Antoniou AC | doi: 10.1016/j.ajhg.2008.02.008 |
21799032 | Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. | Cancer Res | 2011 Sep 1 | Rebbeck TR | doi: 10.1158/0008-5472.CAN-11-0773 |
20204502 | Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. | Breast Cancer Res Treat | 2010 Dec | van der Kolk DM | doi: 10.1007/s10549-010-0805-3 |
23050611 | Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK. | Clin Genet | 2013 Jul | Ingham SL | doi: 10.1111/cge.12035 |
25849179 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. | JAMA | 2015 Apr 7 | Rebbeck TR | doi: 10.1001/jama.2014.5985. |
25403427 | The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. | BMC Cancer | 2014 Nov 17 | Al-Moghrabi N | doi: 10.1186/1471-2407-14-830. |
18312450 | Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families. | Clin Genet | 2008 Apr | Evans DG | doi: 10.1111/j.1399-0004.2008.00974.x |
23935836 | Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases. | PLoS One | 2013 Jul 23 | Blanco A | doi: 10.1371/journal.pone.0067538 |
18098285 | On the dynamics of breast tumor development in women carrying germline BRCA1 and BRCA2 mutations. | Int J Cancer | 2008 Apr 15 | Simon R | - |
21410590 | Mutational screening of the BRCA1 gene in sporadic breast cancer in Kazakhstan population. | Breast J | 2011 May-Jun | Akilzhanova A | doi: 10.1111/j.1524-4741.2011.01068.x |
17557253 | [Analysis of the mutation of BRCA1 gene in 70 Uigur women breast cancer patients in Xinjiang]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2007 Jun | Fu XG | - |
23544013 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. | PLoS Genet | 2013 | Couch FJ | doi: 10.1371/journal.pgen.1003212 |
22443199 | Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. | J Intern Med | 2012 Apr | Barnes DR | doi: 10.1111/j.1365-2796.2011.02502.x. |
26006218 | Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers. | Cancer Causes Control | 2015 Aug | Kim J | doi: 10.1007/s10552-015-0601-9 |
21221768 | Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2011 May | Metcalfe K | doi: 10.1007/s10549-010-1336-7 |
20852631 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. | Nat Genet | 2010 Oct | Antoniou AC | doi: 10.1038/ng.669 |
21496870 | Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers. | Hum Pathol | 2011 Nov | Mangia A | doi: 10.1016/j.humpath.2011.01.010 |
20507347 | The contribution of founder mutations in BRCA1 to breast cancer in Belarus. | Clin Genet | 2010 Oct | Uglanitsa N | doi: 10.1111/j.1399-0004.2010.01439.x. |
17987791 | Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India. | J Exp Clin Cancer Res | 2007 Sep | Vinodkumar B | - |
16271956 | Search for large genomic alterations of the BRCA1 gene in a Finnish population. | Cancer Genet Cytogenet | 2005 Nov | Laurila E | - |
21598239 | Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. | Cancer | 2012 Jan 15 | Stadler ZK | doi: 10.1002/cncr.26191 |
18835712 | Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations. | Breast | 2008 Dec | Haitian Z | doi: 10.1016/j.breast.2008.08.003 |
22729394 | A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. | Cancer Epidemiol Biomarkers Prev | 2012 Aug | Ding YC | - |
12677558 | Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. | Am J Hum Genet | 2003 May | Antoniou A | - |
18971141 | Occult fallopian tube cancer in a patient with BRCA1 breast cancer. | J Minim Invasive Gynecol | 2008 Nov-Dec | Brown JV 3rd | doi: 10.1016/j.jmig.2008.07.007. |
21324516 | Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. | Gynecol Oncol | 2011 May 1 | Zhang S | doi: 10.1016/j.ygyno.2011.01.020 |
12872263 | Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore. | Hum Mutat | 2003 Aug | Lee AS | - |
20472656 | BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries. | J Med Genet | 2010 Aug | Evans DG | doi: 10.1136/jmg.2009.075770 |
15345109 | BRCA1 mutations in a population-based study of breast cancer in Stockholm County. | Genet Test | 2004 Summer | Margolin S | - |
26625823 | Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India. | Asian Pac J Cancer Prev | 2015 | Chakraborty A | - |
21123638 | Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. | Mayo Clin Proc | 2010 Dec | Pruthi S | doi: 10.4065/mcp.2010.0414. |
26467044 | Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age. | Breast Cancer Res Treat | 2015 Nov | Drooger J | - |
12815598 | A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1. | Hum Mutat | 2003 Jul | Southey MC | - |
20878485 | An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations. | Fam Cancer | 2011 Mar | Ratnayake P | doi: 10.1007/s10689-010-9383-0. |
24566764 | Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea. | Fam Cancer | 2014 Jun | Cho JY | doi: 10.1007/s10689-014-9704-9. |
18030340 | Negative selection on BRCA1 susceptibility alleles sheds light on the population genetics of late-onset diseases and aging theory. | PLoS One | 2007 Nov 21 | Pavard S | - |
24191513 | [Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries]. | Ginekol Pol | 2013 Sep | Menkiszak J | - |
21614564 | Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. | Breast Cancer Res Treat | 2012 Apr | Zhang J | doi: 10.1007/s10549-011-1596-x |
17497966 | Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation. | ANZ J Surg | 2007 May | Suthers GK | - |
16912201 | Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers. | Cancer Res | 2006 Aug 15 | Deans AJ | - |
17428325 | Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. | Breast Cancer Res | 2007 | Baynes C | - |
20840664 | Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. | BJU Int | 2011 Jan | Mitra AV | doi: 10.1111/j.1464-410X.2010.09648.x |
26467043 | Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? | Breast Cancer Res Treat | 2015 Nov | Semple J | - |
25337278 | Prevalence of BRCA1 gene mutation in breast cancer patients in Guangxi, China. | Int J Clin Exp Pathol | 2014 Aug 15 | Sun L | - |
22113258 | Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers? | Breast Cancer Res Treat | 2012 Apr | Bernholtz S | doi: 10.1007/s10549-011-1886-3 |
19661094 | Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer. | Cancer Epidemiol Biomarkers Prev | 2009 Aug | Dombernowsky SL | doi: 10.1158/1055-9965.EPI-09-0447. |
15986445 | Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. | Int J Cancer | 2005 Dec 20 | Cullinane CA | - |
21063910 | Two BRCA1/2 founder mutations in Jews of Sephardic origin. | Fam Cancer | 2011 Mar | Sagi M | doi: 10.1007/s10689-010-9395-9. |
23335114 | Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non-small cell lung cancer. | Cancer | 2013 Feb 15 | Harada H | doi: 10.1002/cncr.27754 |
17673924 | Activation of BTAK expression in primary ovarian surface epithelial cells of prophylactic ovaries. | Mod Pathol | 2007 Oct | Zhang Z | - |
22032251 | Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia. | BMC Med Genet | 2011 Oct 27 | Plakhins G | doi: 10.1186/1471-2350-12-147. |
19920816 | Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). | Br J Cancer | 2009 Dec 15 | Osorio A | doi: 10.1038/sj.bjc.6605416 |
19298662 | The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. | BMC Cancer | 2009 Mar 19 | Young SR | doi: 10.1186/1471-2407-9-86. |
17520345 | Prognostic value of BRCA1 mutations in familial breast cancer patients affected by a second primary cancer. | Fam Cancer | 2007 | Elsakov P | - |
14507240 | BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. | Asian Pac J Cancer Prev | 2003 Jul-Sep | Rajkumar T | - |
21691706 | Clinical implications for BRCA gene mutation in breast cancer. | Mol Biol Rep | 2012 Mar | Xu J | doi: 10.1007/s11033-011-1073-y |
19372713 | Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer. | Onkologie | 2009 Apr | Skasko E | doi: 10.1159/000200930 |
23011509 | Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. | Breast Cancer Res Treat | 2012 Nov | Stevens KN | doi: 10.1007/s10549-012-2255-6 |
24153343 | Dietary intake and breast cancer among carriers and noncarriers of BRCA mutations in the Korean Hereditary Breast Cancer Study. | Am J Clin Nutr | 2013 Dec | Ko KP | doi: 10.3945/ajcn.112.057760 |
24321281 | Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer. | J Exp Clin Cancer Res | 2013 Dec 9 | Li D | doi: 10.1186/1756-9966-32-102. |
21190077 | BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants. | Breast Cancer Res Treat | 2011 Jul | Delgado L | doi: 10.1007/s10549-010-1320-2 |
27958297 | Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer. | Nat Rev Clin Oncol | 2017 May | George A | doi: 10.1038/nrclinonc.2016.191 |
28448241 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. | J Clin Oncol | 2017 Jul 10 | Lecarpentier J | doi: 10.1200/JCO.2016.69.4935 |
28294317 | The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing. | Int J Cancer | 2017 Jul 1 | Lang GT | doi: 10.1002/ijc.30692 |
29058716 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. | Nat Genet | 2017 Dec | Milne RL | doi: 10.1038/ng.3785 |
27767231 | Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas. | Hum Mutat | 2017 Feb | Weren RD | doi: 10.1002/humu.23137 |
27601588 | Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer. | Clin Cancer Res | 2017 Mar 1 | von Wahlde MK | doi: 10.1158/1078-0432.CCR-16-0889 |
28562349 | MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. | Oncotarget | 2017 Jun 20 | Gao S | doi: 10.18632/oncotarget.17816. |
29511213 | Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1. | Nat Commun | 2018 Mar 6 | Hern??ndez G | doi: 10.1038/s41467-018-03433-3. |
28087643 | Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance. | Clin Cancer Res | 2017 Jul 1 | Afghahi A | doi: 10.1158/1078-0432.CCR-16-2174 |
28490613 | The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium. | J Med Genet | 2018 Jan | Moghadasi S | doi: 10.1136/jmedgenet-2017-104560 |
29338689 | Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer. | BMC Cancer | 2018 Jan 16 | Park JS | doi: 10.1186/s12885-017-3940-y. |
29086229 | The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel. | Breast Cancer Res Treat | 2018 Feb | Bernstein-Molho R | doi: 10.1007/s10549-017-4551-7 |
29483665 | The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position? | Eur J Hum Genet | 2018 Jun | Teixeira N | doi: 10.1038/s41431-018-0111-9 |
30221688 | Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses. | Int J Mol Med | 2018 Dec | Wang Z | doi: 10.3892/ijmm.2018.3870 |
29335924 | BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia. | Breast Cancer Res Treat | 2018 Apr | Jakimovska M | doi: 10.1007/s10549-017-4642-5 |
29318406 | Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer. | Breast Cancer Res Treat | 2018 Apr | Liljegren A | doi: 10.1007/s10549-017-4639-0 |
29875420 | Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake. | Genet Med | 2019 Jan | Nilsson MP | doi: 10.1038/s41436-018-0021-9 |
30804502 | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | Nat Cell Biol | 2019 Mar | Nakamura K | doi: 10.1038/s41556-019-0282-9 |
22253870 | BRCAness profile of sporadic ovarian cancer predicts disease recurrence. | PLoS One | 2012 | Wysham WZ | doi: 10.1371/journal.pone.0030042 |
21978880 | Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients. | Cancer Epidemiol | 2012 Apr | Ben Gacem R | doi: 10.1016/j.canep.2011.09.001 |
20216074 | Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. | Genet Med | 2010 May | Petrucelli N | doi: 10.1097/GIM.0b013e3181d38f2f. |
23232912 | Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India. | Fam Cancer | 2013 Sep | Chakraborty A | doi: 10.1007/s10689-012-9590-y. |
19372557 | Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers. | Mol Cancer Ther | 2009 Apr | Santarosa M | doi: 10.1158/1535-7163.MCT-08-0951. |
26426992 | First description of a sporadic breast cancer in a woman with BRCA1 germline mutation. | Oncotarget | 2015 Nov 3 | Curtit E | doi: 10.18632/oncotarget.5348. |
25824734 | The spectrum of genetic mutations in breast cancer. | Asian Pac J Cancer Prev | 2015 | Sheikh A | - |
24770866 | BRCA1 founder mutations compared to ovarian cancer in Belarus. | Fam Cancer | 2014 Sep | Savanevich A | doi: 10.1007/s10689-014-9721-8. |
24528374 | Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. | Clin Genet | 2015 Mar | Szwiec M | doi: 10.1111/cge.12360 |
17688236 | Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. | Hum Mutat | 2007 Dec | Ramus SJ | - |
21643751 | Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review. | Mol Biol Rep | 2012 Mar | Wang F | doi: 10.1007/s11033-011-0958-0 |
19016756 | Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. | Cancer Sci | 2008 Oct | Sugano K | doi: 10.1111/j.1349-7006.2008.00944.x. |
21119070 | Allelic imbalance in BRCA1 and BRCA2 gene expression and familial ovarian cancer. | Cancer Epidemiol Biomarkers Prev | 2011 Jan | Shen J | doi: 10.1158/1055-9965.EPI-10-0720 |
18695886 | BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model. | Int J Oncol | 2008 Sep | Yu X | - |
24145998 | BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer. | Oncol Rep | 2014 Jan | Sambiasi D | doi: 10.3892/or.2013.2802 |
19246281 | [Analysis of BRCA1 gene mutations in patients with early-onset breast cancer and their affected relatives in Guangdong province]. | Nan Fang Yi Ke Da Xue Xue Bao | 2009 Feb | Zhou J | - |
20638108 | Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients. | Gynecol Oncol | 2010 Oct | Aktas D | doi: 10.1016/j.ygyno.2010.05.018 |
23846919 | BRCA and pancreatic cancer. | JOP | 2013 Jul 10 | Brennan GT | doi: 10.6092/1590-8577/1652. |
24625110 | A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. | Breast Cancer Res | 2014 Mar 14 | McMullin RP | doi: 10.1186/bcr3625. |
22425665 | BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants. | Gynecol Oncol | 2012 Jun | Tazzite A | doi: 10.1016/j.ygyno.2012.03.007 |
20234119 | Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial. | Public Health Genomics | 2010 | Halbert CH | doi: 10.1159/000293990 |
24600974 | Association of BRCA1 K1183R polymorphism with survival in BRCA1/2-negative chinese familial breast cancer. | Clin Lab | 2014 | Pei R | - |
22262859 | The C-terminal proteolytic fragment of the breast cancer susceptibility type 1 protein (BRCA1) is degraded by the N-end rule pathway. | J Biol Chem | 2012 Mar 2 | Xu Z | doi: 10.1074/jbc.M111.301002 |
25372568 | Breast cancer following ovarian cancer in BRCA mutation carriers. | JAMA Surg | 2014 Dec | Gangi A | doi: 10.1001/jamasurg.2014.1081. |
17319787 | The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families. | Neoplasma | 2007 | Konecny M | - |
26010302 | Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients. | Clin Genet | 2016 Mar | De Brakeleer S | doi: 10.1111/cge.12620 |
23532817 | Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer. | Med Oncol | 2013 Jun | Moiseyenko VM | doi: 10.1007/s12032-013-0545-4 |
20467918 | ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer. | Med Oncol | 2011 Dec | Su C | doi: 10.1007/s12032-010-9553-9 |
23730208 | BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2. | Neoplasia | 2013 Jun | May T | - |
17470134 | Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. | Clin Genet | 2007 Apr | Lim YK | - |
25267367 | Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases. | Breast Dis | 2015 | Tandon M | doi: 10.3233/BD-140387. |
18094425 | BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy. | Clin Cancer Res | 2007 Dec 15 | Quinn JE | - |
20384635 | Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells. | Cancer Sci | 2010 Jun | El-Tanani MK | doi: 10.1111/j.1349-7006.2010.01561.x |
18400253 | Expression of BRCA1 protein in breast cancer and its prognostic significance. | Hum Pathol | 2008 Jun | Rakha EA | doi: 10.1016/j.humpath.2007.10.011 |
22311183 | Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers. | J Cancer Res Clin Oncol | 2012 May | Custodio A | doi: 10.1007/s00432-012-1161-y |
20514903 | [The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009]. | Przegl Lek | 2009 | Blecharz P | - |
15447980 | Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. | Clin Cancer Res | 2004 Sep 15 | Zuhlke KA | - |
23172369 | BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies. | Cell Cycle | 2012 Dec 1 | Martinez-Outschoorn UE | doi: 10.4161/cc.22776 |
15168169 | Identification and evaluation of 55 genetic variations in the BRCA1 and the BRCA2 genes of patients from 50 Japanese breast cancer families. | J Hum Genet | 2004 | Kawahara M | - |
18752448 | BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies. | Genet Test | 2008 Sep | Pal T | doi: 10.1089/gte.2007.0108. |
22652532 | Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms. | J Med Genet | 2012 Jul | Schulz E | doi: 10.1136/jmedgenet-2011-100674 |
21890493 | Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. | Hum Mol Genet | 2011 Dec 1 | Cox DG | doi: 10.1093/hmg/ddr388 |
22591913 | Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing. | Hum Pathol | 2012 Nov | de la Cruz J | doi: 10.1016/j.humpath.2012.02.002 |
17761984 | Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. | J Clin Oncol | 2007 Sep 1 | Callahan MJ | - |
24526546 | MRI volumetric analysis of breast fibroglandular tissue to assess risk of the spared nipple in BRCA1 and BRCA2 mutation carriers. | Ann Surg Oncol | 2014 May | Baltzer HL | doi: 10.1245/s10434-014-3532-x |
22753153 | Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. | Hum Mutat | 2012 Dec | Brewster BL | doi: 10.1002/humu.22159 |
20306497 | Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. | Mol Carcinog | 2010 Jun | Yarden RI | doi: 10.1002/mc.20618. |
18095154 | Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. | Breast Cancer Res Treat | 2008 Nov | Walker LC | - |
23066998 | Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation. | Clin Genet | 2013 Jul | Senst N | doi: 10.1111/cge.12037 |
24629213 | Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. | Environ Health | 2014 Mar 16 | Ghisari M | doi: 10.1186/1476-069X-13-19. |
25273865 | Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases' occurrence. | Med Oncol | 2014 Nov | Medimegh I | doi: 10.1007/s12032-014-0255-6 |
21918853 | Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population. | Fam Cancer | 2012 Mar | de Juan Jim??nez I | doi: 10.1007/s10689-011-9481-7. |
19863560 | The contribution of founder mutations to early-onset breast cancer in French-Canadian women. | Clin Genet | 2009 Nov | Ghadirian P | doi: 10.1111/j.1399-0004.2009.01277.x. |
18559594 | BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. | Clin Cancer Res | 2008 Jun 15 | Soegaard M | doi: 10.1158/1078-0432.CCR-07-4806. |
17719744 | Identification and in silico analysis of functional SNPs of the BRCA1 gene. | Genomics | 2007 Oct | Rajasekaran R | - |
18285832 | Uptake of testing for BRCA1/2 mutations in South East Scotland. | Eur J Hum Genet | 2008 Aug | Holloway SM | doi: 10.1038/ejhg.2008.17 |
23483928 | Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies. | PLoS One | 2013 | Bianco A | doi: 10.1371/journal.pone.0057781 |
22034289 | High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. | Int J Cancer | 2012 Sep 1 | Fackenthal JD | doi: 10.1002/ijc.27326 |
18092194 | High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. | Int J Cancer | 2012 Sep 1 | Fackenthal JD | doi: 10.1002/ijc.27326 |
25919761 | Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations. | Breast Cancer Res Treat | 2008 Nov | Seymour IJ | - |
22569005 | Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res | 2014 Dec 31 | Kuchenbaecker KB | doi: 10.1186/s13058-014-0492-9. |
26727920 | DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct. | BMC Womens Health | 2012 May 8 | Sie AS | doi: 10.1186/1472-6874-12-12. |
25948282 | Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. | Ann Surg Oncol | 2016 May | Catts ZA | doi: 10.1245/s10434-015-5026-x |
20455026 | New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing. | BMC Med Genomics | 2015 May 7 | Kluska A | doi: 10.1186/s12920-015-0092-2. |
17426707 | Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations. | Fam Cancer | 2010 Sep | Steffensen AY | doi: 10.1007/s10689-010-9345-6. |
20820192 | No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. | Br J Cancer | 2007 May 7 | Hermsen BB | - |
19012246 | BRCA1 affects global DNA methylation through regulation of DNMT1. | Cell Res | 2010 Nov | Shukla V | doi: 10.1038/cr.2010.128 |
17922413 | BRCA1 expression and molecular alterations in familial breast cancer. | Histol Histopathol | 2009 Jan | Mangia A | doi: 10.14670/HH-24.69. |
25437005 | [BRCA1 germ line mutations in Chinese early-onset breast cancer patients]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2007 Oct | Li WF | - |
27129401 | A genomic instability score in discriminating nonequivalent outcomes of BRCA1/2 mutations and in predicting outcomes of ovarian cancer treated with platinum-based chemotherapy. | PLoS One | 2014 Dec 1 | Zhang S | doi: 10.1371/journal.pone.0113169 |
15803125 | Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients. | BMC Res Notes | 2016 Apr 29 | Jouhadi H | doi: 10.1186/s13104-016-2057-8. |
26246475 | Promoter usage of BRCA1-IRIS. | Nat Cell Biol | 2005 Apr | Kvist A | - |
15131401 | Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes. | Oncotarget | 2015 Sep 22 | Cochran RL | doi: 10.18632/oncotarget.4595. |
25129345 | BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect. | Fam Cancer | 2004 | Muller D | - |
16567799 | Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. | Breast Cancer Res Treat | 2014 Sep | Byrski T | doi: 10.1007/s10549-014-3100-x |
24518526 | BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells. | J Biol Chem | 2006 May 26 | Kang HJ | - |
21989927 | BRCA mutations in prostate cancer patients. | Clin Adv Hematol Oncol | 2013 | Olmos D | - |
21666725 | Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. | Fam Cancer | 2012 Mar | Ghiorzo P | doi: 10.1007/s10689-011-9483-5. |
23982851 | Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation. | Oncogene | 2012 Jan 5 | Lee MH | doi: 10.1038/onc.2011.217 |
18521744 | Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC). | Clin Transl Oncol | 2014 Mar | Andr??s R | doi: 10.1007/s12094-013-1070-9 |
17952592 | BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. | Breast Cancer Res Treat | 2009 May | Xu X | doi: 10.1007/s10549-008-0075-5 |
21553119 | Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients. | Breast Cancer Res Treat | 2008 Sep | Kriege M | - |
15170666 | Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing. | Breast Cancer Res Treat | 2012 Feb | De Leeneer K | doi: 10.1007/s10549-011-1544-9 |
24629067 | The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations. | Int J Cancer | 2004 Jul 20 | Rodr??guez-L??pez R | - |
26698676 | Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer. | BMC Cancer | 2014 Mar 14 | Fang YY | doi: 10.1186/1471-2407-14-188. |
20487263 | Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. | Fertil Steril | 2016 Mar | Gronwald J | doi: 10.1016/j.fertnstert.2015.11.034 |
20804917 | Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway. | Cancer Sci | 2010 Jul | Wang YQ | doi: 10.1111/j.1349-7006.2010.01568.x |
26183948 | Novel BRCA1/2 mutations in Serbian breast and breast-ovarian cancer patients with hereditary predisposition. | Cancer Genet Cytogenet | 2010 Oct 1 | Dobrici J | doi: 10.1016/j.cancergencyto.2010.06.001. |
15723343 | Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients. | BMC Cancer | 2015 Jul 17 | Dodova RI | doi: 10.1186/s12885-015-1516-2. |
24458845 | in gene expression and genetic integrity. | J Cell Biochem | 2005 Apr 15 | Aiyar S | - |
27221860 | Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. | Breast Cancer Res Treat | 2014 Feb | Kotsopoulos J | doi: 10.1007/s10549-013-2823-4 |
22120723 | A Pilot Study on Screening of BRCA1 Mutations (185delAG, 1294del40) in Nepalese Breast Cancer Patients. | Asian Pac J Cancer Prev | 2016 | Bhatta B | - |
25579682 | BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers. | Oncogene | 2012 Aug 9 | Tkocz D | doi: 10.1038/onc.2011.531 |
17968145 | FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patterns. | Genet Res (Camb) | 2014 Oct 8 | Laitman Y | doi: 10.1017/S0016672314000147. |
23877192 | High frequency of BRCA1/2 and p53 somatic inactivation in sporadic ovarian cancer. | J Genet | 2007 Aug | Zikan M | - |
23982256 | Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patients. | Biochem Genet | 2014 Feb | Bensam M | doi: 10.1007/s10528-013-9623-8 |
22402307 | Total skin-sparing mastectomy in BRCA mutation carriers. | Ann Surg Oncol | 2014 Jan | Peled AW | doi: 10.1245/s10434-013-3230-0 |
20652397 | BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls. | Cancer Epidemiol | 2012 Jun | Bosviel R | doi: 10.1016/j.canep.2012.02.001 |
19035454 | The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. | Breast Cancer Res Treat | 2011 Feb | Catucci I | doi: 10.1007/s10549-010-1068-8 |
23110154 | The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer. | Int J Cancer | 2009 Feb 15 | Weberpals J | doi: 10.1002/ijc.23987. |
26195121 | Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer. | PLoS One | 2012 | Pern F | doi: 10.1371/journal.pone.0047993 |
12237281 | Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2. | Breast Cancer Res Treat | 2015 Aug | Park B | doi: 10.1007/s10549-015-3495-z |
21336637 | Cancer Incidence in BRCA1 mutation carriers. | J Natl Cancer Inst | 2002 Sep 18 | Thompson D | - |
26700119 | Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer. | Cell Oncol (Dordr) | 2011 Feb | Heerma van Voss MR | doi: 10.1007/s13402-010-0007-3 |
25722380 | Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers. | J Clin Oncol | 2016 Feb 10 | van den Broek AJ | doi: 10.1200/JCO.2015.62.3942 |
19656998 | Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study. | Ann Oncol | 2015 May | Monk BJ | doi: 10.1093/annonc/mdv071 |
23257159 | Elucidation of the transmission of a novel mutation in BRCA1 (1125delCT) in a family with multiple cases of breast cancer. | Cancer Genomics Proteomics | 2009 Jul-Aug | Razis E | - |
24258259 | Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2. | J Natl Cancer Inst | 2013 Jan 16 | McLaughlin JR | doi: 10.1093/jnci/djs494 |
19877752 | Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis. | Breast Cancer Res Treat | 2013 Dec | Wu L | doi: 10.1007/s10549-013-2774-9 |
20215541 | Analysis of BRCA1 and BRCA2 mutations in southern Iranian Breast cancer patients. | Arch Iran Med | 2009 Nov | Fattahi MJ | - |
22901997 | A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. | Clin Cancer Res | 2010 Mar 15 | Sanz DJ | doi: 10.1158/1078-0432.CCR-09-2564 |
16914727 | [BRCA1: a new predictive genomic marker for chemotherapy and radiotherapy of non-small cell lung cancer]. | Zhongguo Fei Ai Za Zhi | 2012 Aug | Li M | doi: 10.3779/j.issn.1009-3419.2012.08.06. |
22673632 | Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. | Mol Cell Biol | 2006 Sep | Muraoka-Cook RS | - |
18071589 | BRCAness: finding the Achilles heel in ovarian cancer. | Oncologist | 2012 | Rigakos G | doi: 10.1634/theoncologist.2012-0028 |
23842040 | Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells. | Int J Biol Sci | 2007 Nov 26 | Aiyar SE | - |
12938098 | Functional analysis of BRCA1 missense variants of uncertain significance in Japanese breast cancer families. | J Hum Genet | 2013 Sep | Kawaku S | doi: 10.1038/jhg.2013.71 |
18286383 | Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany. | Hum Mutat | 2003 Sep | Meyer P | - |
25971130 | Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba. | Fam Cancer | 2008 | Rodriguez RC | doi: 10.1007/s10689-008-9187-7 |
23082475 | [Ethnic aspects of hereditary breast cancer in the region of Siberia]. | Vestn Ross Akad Med Nauk | 2014 | Cherdyntseva NV | - |
20103632 | Detection of BRCA1 and BRCA2 gene mutation in Egyptian females with breast cancer and their relatives by PCR-SSCP method. | Egypt J Immunol | 2011 | Fattouh M | - |
23469205 | BRCA1 represses amphiregulin gene expression. | Cancer Res | 2010 Feb 1 | Lamber EP | doi: 10.1158/0008-5472.CAN-09-2842 |
18060494 | Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. | PLoS One | 2013 | Carraro DM | doi: 10.1371/journal.pone.0057581 |
21455666 | Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain. | Breast Cancer Res Treat | 2008 Nov | Esteban Cardeosa E | - |
25777348 | The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer. | Breast Cancer Res Treat | 2011 Jul | Narod SA | doi: 10.1007/s10549-011-1479-1 |
25971625 | BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer. | Oncologist | 2015 Apr | El Saghir NS | doi: 10.1634/theoncologist.2014-0364 |
17020472 | Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer. | J Cancer Res Clin Oncol | 2015 Nov | Muendlein A | doi: 10.1007/s00432-015-1986-2 |
12353262 | The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews. | Genet Test | 2006 Fall | Kaufman B | - |
20371364 | Subcellular localization of the BRCA1 gene product in mitotic cells. | Genes Chromosomes Cancer | 2002 Nov | Lotti LV | - |
23276146 | BRCA1 role in the mitigation of radiotoxicity and chromosomal instability through repair of clustered DNA lesions. | Chem Biol Interact | 2010 Nov 5 | Hair JM | doi: 10.1016/j.cbi.2010.03.046 |
24489760 | The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients. | Diagn Pathol | 2012 Dec 31 | Zhang Q | doi: 10.1186/1746-1596-7-181. |
23704879 | Telomere length shows no association with BRCA1 and BRCA2 mutation status. | PLoS One | 2014 Jan 29 | Killick E | doi: 10.1371/journal.pone.0086659 |
16792513 | Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2. | PLoS One | 2013 May 21 | Tram E | doi: 10.1371/journal.pone.0062468 |
22116506 | No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. | Genet Test | 2006 Summer | Moisan AM | - |
20570322 | Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer. | Breast Cancer Res Treat | 2012 Feb | Zhang M | doi: 10.1007/s10549-011-1887-2 |
20376556 | Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube. | Gynecol Oncol | 2010 Sep | Vicus D | doi: 10.1016/j.ygyno.2010.05.011 |
12453858 | Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis. | Breast Cancer Res Treat | 2010 Jul | Lee EH | doi: 10.1007/s10549-010-0859-2 |
21520156 | BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling. | Ann Oncol | 2002 Dec | Palmieri G | - |
18269736 | BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data. | Prostate | 2011 Dec | Fachal L | doi: 10.1002/pros.21394 |
26378051 | BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. | Breast Cancer Res | 2008 | Snell C | doi: 10.1186/bcr1858 |
17851763 | miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers. | Oncotarget | 2015 Oct 13 | Vos S | doi: 10.18632/oncotarget.5617. |
24081797 | The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. | Breast Cancer Res Treat | 2008 Jul | Li WF | - |
12647291 | Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin. | Ann Surg Oncol | 2014 May | Kwa M | doi: 10.1245/s10434-013-3277-y |
27002934 | Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription. | J Cell Biochem | 2003 Apr 15 | Somasundaram K | - |
16998496 | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. | Br J Cancer | 2016 Mar 29 | Drew Y | doi: 10.1038/bjc.2016.41 |
23350388 | Clinical management of BRCA1 and BRCA2 mutation carriers. | Oncogene | 2006 Sep 25 | Domchek SM | - |
25447904 | [Loss of heterozygosity (LOH) at BRCA1 loci in primary breast cancers]. | Nihon Rinsho | 2012 Sep | Miyoshi Y | - |
25342642 | Alteration of BRCA1 expression affects alcohol-induced transcription of RNA Pol III-dependent genes. | Gene | 2015 Feb 1 | Zhong Q | doi: 10.1016/j.gene.2014.11.009 |
19383373 | Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. | Breast Cancer Res Treat | 2014 Nov | Zugazagoitia J | doi: 10.1007/s10549-014-3167-4 |
21196292 | Thematic issue on the molecular biology of hereditary ovarian cancer. Preface. | Mol Oncol | 2009 Apr | Tonin PN | doi: 10.1016/j.molonc.2009.02.002 |
25041116 | BRCA1-related gene signature in breast cancer: the role of ER status and molecular type. | Front Biosci (Elite Ed) | 2011 Jan 1 | Lisowska KM | - |
24889916 | Analysis of novel mutations in BRCA1 in Iranian families with breast cancer. | Hereditas | 2014 Jun | Sadr-Nabavi A | doi: 10.1111/hrd2.00040. |
17321670 | BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD). | Eur J Cancer | 2014 Aug | Ruscito I | doi: 10.1016/j.ejca.2014.05.001 |
18762988 | Compromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines. | Cancer Lett | 2007 Aug 8 | Burkitt K | - |
26742938 | Germline BRCA1 mutations predispose to pancreatic adenocarcinoma. | Hum Genet | 2008 Oct | Al-Sukhni W | doi: 10.1007/s00439-008-0554-0 |
21769658 | Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics. | Clin Transl Oncol | 2016 Oct | Moreno L | doi: 10.1007/s12094-015-1470-0 |
16168118 | Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members. | Breast Cancer Res Treat | 2012 Apr | Thomassen M | doi: 10.1007/s10549-011-1674-0 |
26919240 | High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. | Breast Cancer Res | 2005 | Pohlreich P | - |
20567915 | miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells. | Oncotarget | 2016 Apr 5 | Crippa E | doi: 10.18632/oncotarget.7617. |
21735045 | Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population. | Fam Cancer | 2010 Dec | Negura L | doi: 10.1007/s10689-010-9361-6. |
22252577 | Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes. | Breast Cancer Res Treat | 2012 Apr | Men??ndez M | doi: 10.1007/s10549-011-1661-5 |
17697535 | The relevance of BRCA genetics to prostate cancer pathogenesis and treatment. | Clin Adv Hematol Oncol | 2011 Oct | Sundararajan S | - |
23614934 | A mutation in the 5' untranslated region of the BRCA1 gene in sporadic breast cancer causes downregulation of translation efficiency. | J Int Med Res | 2007 Jul-Aug | Wang J | - |
18205043 | Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67. | Pathobiology | 2013 | Hassanein M | doi: 10.1159/000339432 |
15876585 | Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. | Breast Cancer Res Treat | 2008 Dec | Gronwald J | doi: 10.1007/s10549-008-9892-9 |
22076508 | Mutational analysis of the BRCA1 gene in 30 Czech ovarian cancer patients. | J Genet | 2005 Apr | Zikan M | - |
18662409 | Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese. | Med Oncol | 2012 Sep | Pang D | doi: 10.1007/s12032-011-0100-0 |
17922257 | Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals. | BMC Cancer | 2008 Jul 29 | De Silva W | doi: 10.1186/1471-2407-8-214. |
25586199 | Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia. | J Hum Genet | 2007 | Troudi W | - |
19383374 | Two novel frameshift mutations in BRCA2 gene detected by next generation sequencing in a survey of Spanish patients of breast cancer. | Clin Transl Oncol | 2015 Jul | Hernan I | doi: 10.1007/s12094-014-1271-x |
21425892 | Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. | Mol Oncol | 2009 Apr | Lynch HT | doi: 10.1016/j.molonc.2009.02.004 |
23146957 | Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families. | Twin Res Hum Genet | 2011 Apr | Duffy DL | doi: 10.1375/twin.14.2.111. |
23415752 | X chromosome inactivation pattern in BRCA gene mutation carriers. | Eur J Cancer | 2013 Mar | Manoukian S | doi: 10.1016/j.ejca.2012.10.013 |
18158280 | BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation. | Mol Oncol | 2013 Jun | Stordal B | doi: 10.1016/j.molonc.2012.12.007 |
23928241 | Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999. | Eur J Med Genet | 2008 Mar-Apr | Chodick G | - |
25070656 | Breast magnetic resonance imaging for screening high-risk women. | Magn Reson Imaging Clin N Am | 2013 Aug | Sung JS | doi: 10.1016/j.mric.2013.02.006 |
20177704 | From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo. | BMC Public Health | 2014 Jul 28 | Luyeye Mvila G | doi: 10.1186/1471-2458-14-759. |
26187060 | Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer. | J Cancer Res Clin Oncol | 2010 Nov | Bozhanov SS | doi: 10.1007/s00432-010-0824-9 |
21898151 | Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. | J Med Genet | 2016 Jan | Kwong A | doi: 10.1136/jmedgenet-2015-103132 |
20458532 | Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. | Fam Cancer | 2012 Mar | Cohen JV | doi: 10.1007/s10689-011-9480-8. |
16843109 | No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families. | Breast Cancer Res Treat | 2011 Jan | Korde LA | doi: 10.1007/s10549-010-0923-y |
20807450 | Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. | Cancer Genet Cytogenet | 2006 Jul 15 | Thomassen M | - |
18645608 | Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. | BMC Cancer | 2010 Sep 1 | Turkovic L | doi: 10.1186/1471-2407-10-466. |
16331276 | BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases. | Int J Med Sci | 2008 Jul 8 | Uhrhammer N | - |
21570976 | BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). | Oncogene | 2006 Mar 2 | Williamson EA | - |
15319244 | The BRCA1 ubiquitin ligase and homologous recombination repair. | FEBS Lett | 2011 Sep 16 | Ohta T | doi: 10.1016/j.febslet.2011.05.005 |
16760288 | BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. | Ann Oncol | 2004 Sep | Rogozi??ska-Szczepka J | - |
26057449 | Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. | Ann Oncol | 2006 Jun | Augello C | - |
27221885 | Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer. | Br J Cancer | 2015 Jul 28 | Santivasi WL | doi: 10.1038/bjc.2015.208 |
16998499 | Screening of BRCA1/2 Mutations Using Direct Sequencing in Indonesian Familial Breast Cancer Cases. | Asian Pac J Cancer Prev | 2016 | Anwar SL | - |
17145961 | Basal-like breast cancer and the BRCA1 phenotype. | Oncogene | 2006 Sep 25 | Turner NC | - |
22864640 | BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin. | J Cell Biol | 2006 Dec 4 | Pageau GJ | - |
20848184 | High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer. | Fam Cancer | 2012 Dec | Gaj P | doi: 10.1007/s10689-012-9560-4. |
23317271 | Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer. | Breast Cancer Res Treat | 2011 Feb | Lheureux S | doi: 10.1007/s10549-010-1165-8 |
18559571 | Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from North-East India. | Asian Pac J Cancer Prev | 2012 | Hansa J | - |
23657760 | Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer. | Cancer Epidemiol Biomarkers Prev | 2008 Jun | Byrd LM | doi: 10.1158/1055-9965.EPI-07-2792. |
15485898 | Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer. | Fam Cancer | 2013 Dec | Bielinska B | doi: 10.1007/s10689-013-9647-6. |
25531315 | Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation. | Mol Cell Biol | 2004 Nov | Zimmerman ES | - |
23569316 | FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer. | Oncogene | 2015 Sep 24 | Gong C | doi: 10.1038/onc.2014.421 |
17180310 | Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. | J Clin Oncol | 2013 May 10 | Castro E | doi: 10.1200/JCO.2012.43.1882 |
26824983 | Genetic instability in the RAD51 and BRCA1 regions in breast cancer. | Cell Mol Biol Lett | 2007 | Nowacka-Zawisza M | - |
22053997 | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. | Oncotarget | 2016 Feb 16 | Lin PH | doi: 10.18632/oncotarget.7027. |
15900600 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. | Breast Cancer Res | 2011 | Mulligan AM | doi: 10.1186/bcr3052 |
12497638 | Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. | Int J Cancer | 2005 Nov 1 | Hughes DJ | - |
23407556 | BRCA1 germline mutations in Indian familial breast cancer. | Hum Mutat | 2003 Jan | Valarmathi MT | - |
22798144 | BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations. | J Thorac Oncol | 2013 Mar | Karachaliou N | doi: 10.1097/JTO.0b013e31827db621. |
18258506 | Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer. | Breast Cancer Res Treat | 2012 Aug | Kim H | doi: 10.1007/s10549-012-2159-5 |
19484476 | The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets. | Clin Transl Oncol | 2008 Feb | Garc??a MJ | - |
18165637 | Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. | J Cancer Res Clin Oncol | 2009 Nov | Huo X | doi: 10.1007/s00432-009-0604-6 |
15345110 | BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy. | J Clin Oncol | 2008 Jan 1 | Malacrida S | doi: 10.1200/JCO.2007.13.2118. |
21887486 | Characterization of two novel BRCA1 germ-line mutations involving splice donor sites. | Genet Test | 2004 Summer | Brose MS | - |
19671671 | BRCA1-mediated signaling pathways in ovarian carcinogenesis. | Funct Integr Genomics | 2012 Mar | Karve TM | doi: 10.1007/s10142-011-0251-2 |
17160431 | Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. | Mol Cancer Res | 2009 Aug | Willers H | doi: 10.1158/1541-7786.MCR-09-0149 |
20215423 | Improved survival in BRCA2 carriers with ovarian cancer. | Fam Cancer | 2007 | Pal T | - |
18782836 | Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin. | Mol Cancer Res | 2010 Mar | Li H | doi: 10.1158/1541-7786.MCR-09-0403 |
19843326 | Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. | J Med Genet | 2009 Jan | Chan KY | doi: 10.1136/jmg.2007.057174 |
20683152 | Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. | Breast Cancer Res | 2009 | Neuhausen SL | doi: 10.1186/bcr2414. |
24797986 | BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. | Dis Markers | 2010 | Cherbal F | doi: 10.3233/DMA-2010-0718. |
26869327 | BRCA1 gene-related hereditary susceptibility to breast and ovarian cancer in Latvia. | Adv Med Sci | 2014 Mar | Tihomirova L | doi: 10.1016/j.advms.2013.09.002 |
23624750 | Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer. | JAMA Oncol | 2016 Jun 1 | Blazer KR | doi: 10.1001/jamaoncol.2015.5975. |
22333603 | Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer. | Breast Cancer Res Treat | 2013 Jun | Campos B | doi: 10.1007/s10549-013-2538-6 |
21987798 | BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. | Br J Cancer | 2012 Mar 13 | Robertson L | doi: 10.1038/bjc.2012.31 |
23409019 | Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. | Proc Natl Acad Sci U S A | 2011 Oct 25 | Konishi H | doi: 10.1073/pnas.1110969108 |
14722926 | Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. | PLoS One | 2013 | Gracia-Aznarez FJ | doi: 10.1371/journal.pone.0055681 |
18256760 | Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. | Hum Mutat | 2004 Feb | Valarmathi MT | - |
20513533 | High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer. | Bull Exp Biol Med | 2007 Jul | Smirnova TY | - |
21591024 | Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population. | Cancer Genet Cytogenet | 2010 Jul 1 | Wang K | doi: 10.1016/j.cancergencyto.2010.03.006. |
20838878 | The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. | Hum Mutat | 2011 Sep | Garcia AI | doi: 10.1002/humu.21539 |
14701743 | A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. | Breast Cancer Res Treat | 2011 Jan | Donenberg T | doi: 10.1007/s10549-010-1156-9 |
20840220 | Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. | Mol Cell Biol | 2004 Jan | Zhang J | - |
16837909 | Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population. | Clin Genet | 2011 Oct | Pertesi M | doi: 10.1111/j.1399-0004.2010.01532.x |
19707196 | Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer. | Exp Oncol | 2006 Jun | Romanowicz-Makowska H | - |
24265793 | The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. | Br J Cancer | 2009 Oct 20 | Sinilnikova OM | doi: 10.1038/sj.bjc.6605279 |
26515461 | Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations. | PLoS One | 2013 Nov 12 | Birkbak NJ | doi: 10.1371/journal.pone.0080023 |
26269803 | BRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivo. | Oncotarget | 2016 Jan 19 | Uziel O | doi: 10.18632/oncotarget.5693. |
17582599 | Oophorectomy benefits in breast cancer patients with BRCA1 mutation. | Post Reprod Health | 2015 Jun | Brown S | - |
21520273 | Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility. | Int J Cancer | 2007 Oct 1 | Barwell J | - |
17612526 | Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. | Genet Epidemiol | 2011 Jul | Capanu M | doi: 10.1002/gepi.20587 |
24591564 | Regulation of BRCA1 messenger RNA stability in human epithelial cell lines and during cell cycle progression. | FEBS Lett | 2007 Jul 24 | Saunus JM | - |
25800897 | Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation. | EMBO J | 2014 Apr 16 | Gardini A | doi: 10.1002/embj.201385567 |
22044689 | Epigenetic changes in BRCA1-mutated familial breast cancer. | Cancer Genet | 2015 May | Downs B | doi: 10.1016/j.cancergen.2015.02.001 |
25863477 | BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia. | Gynecol Oncol | 2012 Feb | Rodr??guez AO | doi: 10.1016/j.ygyno.2011.10.027 |
15591272 | The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. | Breast Cancer Res Treat | 2015 May | Kang E | doi: 10.1007/s10549-015-3377-4 |
20694749 | A protein truncating BRCA1 allele with a low penetrance of breast cancer. | J Med Genet | 2004 Dec | Gorski B | - |
20368571 | Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer. | Fam Cancer | 2010 Dec | Cavallone L | doi: 10.1007/s10689-010-9372-3. |
22734169 | Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. | J Clin Oncol | 2010 May 10 | Malone KE | doi: 10.1200/JCO.2009.24.2495 |
18090912 | Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario. | Can Fam Physician | 2012 May | Vanstone M | - |
21708937 | BRCA1 mutations and prostate cancer in Poland. | Eur J Cancer Prev | 2008 Feb | Cybulski C | - |
19839046 | Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. | Cancer Epidemiol Biomarkers Prev | 2011 Aug | Neuhausen SL | doi: 10.1158/1055-9965.EPI-10-1336 |
21765473 | Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency. | Genes Chromosomes Cancer | 2010 Jan | Rennstam K | doi: 10.1002/gcc.20723. |
27297669 | c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. | Oncogene | 2012 Feb 16 | Regan JL | doi: 10.1038/onc.2011.289 |
23548269 | Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium. | Tumour Biol | 2016 Sep | Dimitrova D | - |
24244370 | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | Cancer Res | 2013 Jun 15 | Huntoon CJ | doi: 10.1158/0008-5472.CAN-13-0110 |
20919953 | An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing. | PLoS One | 2013 Nov 11 | Stead LF | doi: 10.1371/journal.pone.0078823 |
11857749 | Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay. | Cancer Invest | 2011 Jan | Manguolu E | doi: 10.3109/07357907.2010.512599 |
20809358 | Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. | Hum Mutat | 2002 Mar | Khoo US | - |
19083511 | Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects. | Breast Cancer Res Treat | 2011 Apr | Lu PH | doi: 10.1007/s10549-010-1151-1 |
26254840 | Understanding genetic analysis for breast cancer and its implications for plastic surgery. | Aesthet Surg J | 2008 Jan-Feb | Soltanian H | doi: 10.1016/j.asj.2007.10.002. |
11933198 | Screening for Genetic Testing in Breast Cancer - Are We Missing the Full Picture? | Clin Oncol (R Coll Radiol) | 2016 Mar | McCormick G | doi: 10.1016/j.clon.2015.07.003 |
18523885 | Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:psiBRCA1 recombination. | Hum Mutat | 2002 Apr | Brown MA | - |
21681822 | No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. | Breast Cancer Res Treat | 2009 May | Rebbeck TR | doi: 10.1007/s10549-008-0064-8 |
20353281 | Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer. | Mol Carcinog | 2012 Jun | Deng Y | doi: 10.1002/mc.20813 |
17384678 | Population-based study of BRCA1/2 mutations: family history based criteria identify minority of mutation carriers. | Neoplasma | 2010 | Mateju M | - |
19287951 | BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers. | Oncogene | 2007 Sep 6 | Yuli C | - |
17244477 | A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells. | Int J Oncol | 2009 Apr | Xu J | - |
20727230 | Alternative splicing of breast cancer associated gene BRCA1 from breast cancer cell line. | J Biochem Mol Biol | 2007 Jan 31 | Lixia M | - |
20038817 | BRCA1: linking HOX to breast cancer suppression. | Breast Cancer Res | 2010 | Jin K | doi: 10.1186/bcr2600 |
25675043 | Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-Ras. | Cancer Biol Ther | 2009 Dec | Navaraj A | - |
23624935 | Feelings of Women With Strong Family Histories Who Subsequent to Their Breast Cancer Diagnosis Tested BRCA Positive. | Int J Gynecol Cancer | 2015 May | Joseph M | doi: 10.1097/IGC.0000000000000403. |
20127252 | BRCA1 is a negative modulator of the PRC2 complex. | EMBO J | 2013 May 29 | Wang L | doi: 10.1038/emboj.2013.95 |
20135348 | Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer. | J Cancer Res Clin Oncol | 2010 Sep | Hu H | doi: 10.1007/s00432-010-0795-x |
25266802 | Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. | Breast Cancer Res Treat | 2010 Nov | Ticha I | doi: 10.1007/s10549-010-0745-y |
24131977 | The functional BRCA1 rs799917 genetic polymorphism is associated with gastric cancer risk in a Chinese Han population. | Tumour Biol | 2015 Jan | Wang K | doi: 10.1007/s13277-014-2655-9 |
25486197 | Breast cancer risk in BRCA1 mutation carriers: insight from mouse models. | Ann Oncol | 2013 Nov | Barcellos-Hoff MH | doi: 10.1093/annonc/mdt305. |
23192404 | BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer. | Cell Cycle | 2014 | Li D | doi: 10.4161/15384101.2015.942208. |
25356972 | Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. | Breast Cancer Res Treat | 2013 Jan | Rummel S | doi: 10.1007/s10549-012-2348-2 |
22614657 | BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. | Genet Med | 2015 Jul | Zhen DB | doi: 10.1038/gim.2014.153 |
25724305 | Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. | Cancer | 2012 Jun 1 | Hartman AR | doi: 10.1002/cncr.26576 |
19289372 | Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic. | Breast Cancer Res Treat | 2015 Apr | Ahlborn LB | doi: 10.1007/s10549-015-3313-7 |
20437199 | XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression. | Clin Lung Cancer | 2009 Jan | Bartolucci R | doi: 10.3816/CLC.2009.n.007. |
18296025 | Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer. | Breast Cancer Res Treat | 2010 Nov | Hansen TV | doi: 10.1007/s10549-010-0909-9 |
23055523 | Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent. | Cell Signal | 2008 May | Glover-Collins K | doi: 10.1016/j.cellsig.2008.01.007 |
17990525 | RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1. | J Biol Chem | 2012 Nov 23 | Muoz MC | doi: 10.1074/jbc.M112.410951 |
12362311 | [Novel BRCA1 gene mutations in breast cancer patients from St. Petersburg]. | Genetika | 2007 Sep | Tikhomirova OS | - |
23975082 | [Analysis of mutation sites of BRCA1 gene in Chinese patients with breast cancer]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2002 Oct | Ke Y | - |
23810788 | Added value of family history in counseling about risk of BRCA1/2 mutation in early-onset epithelial ovarian cancer. | Int J Gynecol Cancer | 2013 Oct | Arts-de Jong M | doi: 10.1097/IGC.0b013e3182a1cf71. |
15785095 | The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. | Lancet Oncol | 2013 Aug | Sandhu SK | doi: 10.1016/S1470-2045(13)70240-7 |
22856468 | BRCA1 gene expression in breast cancer in Kuwait: correlation with prognostic parameters. | Med Princ Pract | 2005 Mar-Apr | Amirrad M | - |
24000781 | The BRCA1 S1715N mutation segregates with breast and ovarian cancer in an extended family pedigree. | Clin Genet | 2013 May | Campbell J | doi: 10.1111/j.1399-0004.2012.01933.x |
24947112 | Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis. | Clin Genet | 2014 Jan | Tun NM | doi: 10.1111/cge.12270 |
16760289 | Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. | Int J Cancer | 2015 Feb 1 | Heemskerk-Gerritsen BA | doi: 10.1002/ijc.29032 |
24615043 | BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. | Ann Oncol | 2006 Jun | Capalbo C | - |
20978112 | Specific BRCA1 gene variations amongst young Moroccan breast cancer patients. | Genet Mol Res | 2014 Jan 31 | Tazzite A | doi: 10.4238/2014.January.31.5. |
25485588 | Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. | Cancer Prev Res (Phila) | 2011 Jan | Wong EM | doi: 10.1158/1940-6207.CAPR-10-0212 |
21598251 | A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer. | Cell Cycle | 2014 | Li D | doi: 10.4161/15384101.2014.956507. |
26014432 | Genetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han population. | J Pathol | 2011 Dec | Ruan Y | doi: 10.1002/path.2902 |
24136669 | High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing. | Eur J Hum Genet | 2016 Feb | Plsler L | doi: 10.1038/ejhg.2015.108 |
17333343 | The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. | Breast Cancer Res Treat | 2013 Nov | Valentini A | doi: 10.1007/s10549-013-2729-1 |
25735359 | BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. | Breast Cancer Res Treat | 2007 Apr | Awadelkarim KD | - |
22396490 | BRCA1 and BRCA2 common mutations in iranian breast cancer patients: a meta analysis. | Asian Pac J Cancer Prev | 2015 | Forat-Yazdi M | - |
19763692 | Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors. | Cancer Res | 2012 May 1 | Rottenberg S | doi: 10.1158/0008-5472.CAN-11-4201 |
12019214 | Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations. | Ann Surg Oncol | 2010 Jan | Teller P | doi: 10.1245/s10434-009-0697-9 |
21604195 | CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. | Hum Mol Genet | 2002 May 15 | Nathanson KL | - |
20104584 | Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved? | Fam Cancer | 2011 Sep | Caruso A | doi: 10.1007/s10689-011-9454-x. |
18060491 | Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. | Hum Mutat | 2010 Mar | Borg A | doi: 10.1002/humu.21202. |
17333342 | Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family. | Breast Cancer Res Treat | 2008 Nov | Palanca Suela S | - |
21156238 | Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families. | Breast Cancer Res Treat | 2007 Dec | Buffone A | - |
17063270 | Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients. | Cancer Genet Cytogenet | 2010 Dec | Manguolu E | doi: 10.1016/j.cancergencyto.2010.07.125. |
19029836 | Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil. | Breast Cancer Res Treat | 2007 Jul | Gomes MC | - |
15066328 | Absence of germline BRCA1 mutations in familial pancreatic cancer patients. | Cancer Biol Ther | 2009 Jan | Axilbund JE | - |
23562522 | BRCA1 IVS2-2delA: a deleterious mutation in a family of Asian descent. | Cancer Genet Cytogenet | 2004 Apr 15 | Martin ES | - |
19454503 | Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy. | In Vivo | 2009 May-Jun | Rabiau N | - |
25047471 | Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer. | Ann Surg Oncol | 2014 Oct | Noori SF | doi: 10.1245/s10434-014-3904-2 |
22776961 | Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. | Obstet Gynecol | 2012 Aug | Schrader KA | doi: 10.1097/AOG.0b013e31825f3576. |
19269198 | Coexpression of the mutated BRCA1 mRNA and p53 mRNA and its association in Chinese prostate cancer. | Urol Oncol | 2011 Mar-Apr | Ding GF | doi: 10.1016/j.urolonc.2009.01.002 |
26106036 | Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence. | Nat Commun | 2015 Jun 24 | Sedic M | doi: 10.1038/ncomms8505. |
25394901 | MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1. | Tumour Biol | 2015 Mar | He X | doi: 10.1007/s13277-014-2814-z |
20862552 | BRCA1 mutations and colorectal cancer in Poland. | Fam Cancer | 2010 Dec | Suchy J | doi: 10.1007/s10689-010-9378-x. |
26483394 | Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients. | Cancer Epidemiol Biomarkers Prev | 2016 Jan | Hu C | doi: 10.1158/1055-9965.EPI-15-0455 |
20452659 | Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. | Gynecol Oncol | 2010 Aug 1 | Vicus D | doi: 10.1016/j.ygyno.2010.03.009 |
24217135 | The influence of BRCA1/BRCA2 mutations on toxicity related to chemotherapy and radiotherapy in early breast cancer patients. | Oncology | 2013 | Huszno J | doi: 10.1159/000354834 |
20972632 | Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution. | Ann Surg Oncol | 2011 Mar | Mislowsky A | doi: 10.1245/s10434-010-1381-9 |
21119368 | BRCA germline mutations in women with uterine serous carcinoma--still a debate. | Int J Gynecol Cancer | 2010 Dec | Lavie O | doi: 10.1111/IGC.0b013e3181cd242f. |
17061047 | Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review. | Breast Cancer Res Treat | 2007 Jan | Bonadona V | - |
18710587 | Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res | 2008 | Rebbeck TR | doi: 10.1186/bcr2115 |
22535016 | Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. | Breast Cancer Res Treat | 2012 Aug | Heidemann S | doi: 10.1007/s10549-012-2050-4 |
17018160 | Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. | BMC Med Genet | 2006 Oct 4 | Saxena S | - |
25816289 | Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis. | PLoS One | 2015 Mar 27 | van den Broek AJ | doi: 10.1371/journal.pone.0120189 |
19549808 | Oral contraceptive use and BRCA penetrance: a case-only study. | Cancer Epidemiol Biomarkers Prev | 2009 Jul | Pasanisi P | doi: 10.1158/1055-9965.EPI-09-0024 |
17262179 | Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. | Breast Cancer Res Treat | 2007 Dec | Beristain E | - |
24145348 | Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. | J Clin Oncol | 2013 Nov 20 | Moorman PG | doi: 10.1200/JCO.2013.48.9021 |
25961039 | Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling. | Biomed Res Int | 2015 | Li D | doi: 10.1155/2015/746970 |
25251729 | Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort. | Genes Chromosomes Cancer | 2015 Jan | Ellberg C | doi: 10.1002/gcc.22217 |
19223505 | Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner. | Clin Cancer Res | 2009 Mar 1 | Schayek H | doi: 10.1158/1078-0432.CCR-08-1440 |
25682074 | Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. | Breast Cancer Res Treat | 2015 Feb | Wong-Brown MW | doi: 10.1007/s10549-015-3293-7 |
23326344 | BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy. | PLoS One | 2013 | Gao Y | doi: 10.1371/journal.pone.0052589 |
24529552 | BRCA1/2 mutation carriers are potentially at higher cardiovascular risk. | Crit Rev Oncol Hematol | 2014 Aug | Arts-de Jong M | doi: 10.1016/j.critrevonc.2014.01.008 |
15803127 | Promoter usage of BRCA1-IRIS. | Nat Cell Biol | 2005 Apr | Elshamy WM | - |
23175448 | BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer. | Anat Rec (Hoboken) | 2013 Feb | Cao W | doi: 10.1002/ar.22628 |
24010542 | High prevalence of BRCA1 founder mutations in Greek breast/ovarian families. | Clin Genet | 2014 Jan | Konstantopoulou I | doi: 10.1111/cge.12274 |
16769276 | The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. | Am J Surg | 2006 Jul | Golshan M | - |
12582017 | BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations. | Cancer Epidemiol Biomarkers Prev | 2003 Feb | Ginolhac SM | - |
12114493 | Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families. | J Med Genet | 2002 Jul | Hofmann W | - |
23941904 | The different impact of BRCA mutations on the survival of epithelial ovarian cancer patients: a retrospective single-center experience. | Oncology | 2013 | Lorusso D | doi: 10.1159/000353786 |
21499684 | Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation. | Breast Cancer Res Treat | 2011 Sep | Bernholtz S | doi: 10.1007/s10549-011-1509-z |
19877382 | Breast cancer immunohistochemical features in young women with BRCA 1/2 mutations. | Exp Oncol | 2009 Sep | Zakhartseva LM | - |
12100744 | Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. | Breast Cancer Res | 2002 | Yassaee VR | - |
24567435 | Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. | J Clin Oncol | 2014 May 20 | Finch AP | doi: 10.1200/JCO.2013.53.2820 |
19197335 | Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer. | J Hum Genet | 2009 Mar | Gu??nard F | doi: 10.1038/jhg.2009.6 |
23984822 | Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer. | Mitochondrial DNA | 2015 Apr | Guti??rrez Povedano C | doi: 10.3109/19401736.2013.825773 |
27083178 | Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial. | Breast Cancer Res Treat | 2016 Apr | Gonz??lez-Rivera M | doi: 10.1007/s10549-016-3792-1 |
18642075 | Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers. | Breast Cancer Res Treat | 2009 Jul | Kontorovich T | doi: 10.1007/s10549-008-0121-3 |
19522853 | BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer. | Cancer Sci | 2009 Sep | Chen Y | doi: 10.1111/j.1349-7006.2009.01225.x |
12242698 | Highlight: BRCA1 and BRCA2 proteins in breast cancer. | Microsc Res Tech | 2002 Oct 1 | Daniel DC | - |
18397521 | Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism. | BMC Cancer | 2008 Apr 8 | Jakubowska A | doi: 10.1186/1471-2407-8-90. |
16826315 | BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. | Fam Cancer | 2006 | Peixoto A | - |
19374245 | [Evaluation of stomatognathic system in BRCA1 gene mutation carriers before and after prophylactic adnexectomy--part II: evaluation of stomatognathic system in BRCA1 gene mutation carriers after prophylactic adnexectomy]. | Ann Acad Med Stetin | 2008 | Chruciel-Nogalska M | - |
22516946 | Germline BRCA1 mutations increase prostate cancer risk. | Br J Cancer | 2012 May 8 | Leongamornlert D | doi: 10.1038/bjc.2012.146. |
26822887 | BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer. | Cell Cycle | 2016 | Sedic M | doi: 10.1080/15384101.2016.1141841. |
14550570 | BRCA1 interacts with FHL2 and enhances FHL2 transactivation function. | FEBS Lett | 2003 Oct 9 | Yan J | - |
25048467 | Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status. | Breast Cancer Res Treat | 2014 Aug | Prat A | doi: 10.1007/s10549-014-3056-x |
27165220 | Mutation Spectra of BRCA Genes in Iranian Women with Early Onset Breast Cancer - 15 Years Experience. | Asian Pac J Cancer Prev | 2016 | Yassaee VR | - |
16222692 | The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. | Cancer | 2005 Dec 1 | Kinney AY | - |
14612409 | BRCA1 inhibition of telomerase activity in cultured cells. | Mol Cell Biol | 2003 Dec | Xiong J | - |
20406939 | Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype. | J Clin Oncol | 2010 May 20 | Gourley C | doi: 10.1200/JCO.2009.25.1082 |
27039761 | BRCA1 Gene Mutations and Influence of Chemotherapy on Autophagy and Apoptotic Mechanisms in Egyptian Breast Cancer Patients. | Asian Pac J Cancer Prev | 2016 | Abdel-Mohsen MA | - |
21356067 | Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. | Breast Cancer Res | 2011 Feb 28 | Kuusisto KM | doi: 10.1186/bcr2832. |
19440381 | Misbehaviour of XIST RNA in breast cancer cells. | PLoS One | 2009 | Sirchia SM | doi: 10.1371/journal.pone.0005559 |
25850293 | [Genotyping of BRCA1, BRCA2 and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips]. | Mol Biol (Mosk) | 2014 Mar-Apr | Nasedkina TV | - |
18594935 | BRCA1 185delAG truncation protein, BRAt, amplifies caspase-mediated apoptosis in ovarian cells. | In Vitro Cell Dev Biol Anim | 2008 Sep-Oct | O'Donnell JD | doi: 10.1007/s11626-008-9122-0 |
19190154 | Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. | Cancer Epidemiol Biomarkers Prev | 2009 Feb | Antoniou AC | doi: 10.1158/1055-9965.EPI-08-0546 |
22739995 | Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. | Breast Cancer Res Treat | 2012 Jul | Zhang J | doi: 10.1007/s10549-012-2136-z |
21869484 | Identification of novel intronic BRCA1 variants of uncertain significance in a Thai hereditary breast cancer family. | J Genet | 2011 Aug | Ratanaphan A | - |
21318380 | Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations. | Fam Cancer | 2011 Jun | Hansen TV | doi: 10.1007/s10689-011-9422-5. |
27221844 | Screening for Del 185 AG and 4627C>A BRCA1 Mutations in Breast Cancer Patients from Lahore, Pakistan. | Asian Pac J Cancer Prev | 2016 | Aziz F | - |
22212556 | The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2012 Apr | Laitman Y | doi: 10.1007/s10549-011-1938-8 |
14559807 | BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. | Cancer Res | 2003 Oct 1 | Quinn JE | - |
27465548 | DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer. | Tumour Biol | 2016 Oct | Cirauqui B | - |
25228385 | miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer. | Breast Cancer Res | 2014 Sep 17 | Tan X | doi: 10.1186/s13058-014-0435-5. |
23458327 | The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. | Clin Genet | 2014 Jan | Akbari MR | doi: 10.1111/cge.12132 |
18204050 | Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. | Hum Mol Genet | 2008 May 1 | Chen X | doi: 10.1093/hmg/ddn022 |
22972572 | Evidence that BRCA1- or BRCA2-associated cancers are not inevitable. | Mol Med | 2012 Dec 6 | Levin B | doi: 10.2119/molmed.2012.00280. |
18513387 | Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family. | BMC Cancer | 2008 May 30 | Evans DG | doi: 10.1186/1471-2407-8-155. |
21653198 | Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. | J Med Genet | 2011 Aug | Evans DG | doi: 10.1136/jmedgenet-2011-100006 |
16533773 | Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer. | Clin Cancer Res | 2006 Mar 1 | Grabsch H | - |
15073127 | Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. | Clin Cancer Res | 2004 Apr 1 | Lakhani SR | - |
19073515 | BRCA1: a new genomic marker for non-small-cell lung cancer. | Clin Lung Cancer | 2008 Nov | Reguart N | doi: 10.3816/CLC.2008.n.048. |
23666017 | Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer. | Int J Gynecol Cancer | 2013 Jun | Secord AA | doi: 10.1097/IGC.0b013e31829527bd. |
17661172 | Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques. | Breast Cancer Res Treat | 2008 Jun | Konecny M | - |
25605143 | Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients. | Asian Pac J Cancer Prev | 2014 | Saelee P | - |
20413709 | A BRCA1 promoter variant (rs11655505) and breast cancer risk. | J Med Genet | 2010 Apr | Verderio P | doi: 10.1136/jmg.2009.073544. |
20221693 | Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. | Breast Cancer Res Treat | 2010 Sep | Stadler ZK | doi: 10.1007/s10549-010-0818-y |
26997744 | Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer. | Dis Markers | 2016 | Henouda S | doi: 10.1155/2016/7869095 |
19841329 | Preventing future cancers by testing women with ovarian cancer for BRCA mutations. | J Clin Oncol | 2010 Feb 1 | Kwon JS | doi: 10.1200/JCO.2008.21.4684 |
21990299 | Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. | JAMA | 2011 Oct 12 | Yang D | doi: 10.1001/jama.2011.1456. |
18819001 | BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. | Breast Cancer Res Treat | 2009 Aug | Ottini L | doi: 10.1007/s10549-008-0194-z |
23957571 | Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations. | Int J Radiat Biol | 2014 Jan | Park H | doi: 10.3109/09553002.2013.835504 |
18940477 | Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes. | Cancer Genet Cytogenet | 2008 Oct 15 | Porhanova NV | doi: 10.1016/j.cancergencyto.2008.06.012. |
25788227 | Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2015 Apr | Laitman Y | doi: 10.1007/s10549-015-3340-4 |
12442275 | BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico. | Hum Mutat | 2002 Dec | Ruiz-Flores P | - |
20470789 | Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. | Life Sci | 2010 Jul 17 | Sharma G | doi: 10.1016/j.lfs.2010.05.001 |
12815604 | The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. | Hum Mutat | 2003 Jul | Hu Z | - |
21343941 | Morphological predictors of BRCA1 germline mutations in young women with breast cancer. | Br J Cancer | 2011 Mar 15 | Southey MC | doi: 10.1038/bjc.2011.41 |
15733268 | Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data. | Clin Genet | 2005 Apr | Kataki A | - |
23975317 | Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. | Ann Surg Oncol | 2013 Oct | Greenup R | doi: 10.1245/s10434-013-3205-1 |
25398451 | Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. | Clin Cancer Res | 2015 Feb 1 | Candido-dos-Reis FJ | doi: 10.1158/1078-0432.CCR-14-2497 |
24728189 | The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. | Hum Mol Genet | 2014 Sep 1 | Song H | doi: 10.1093/hmg/ddu172 |
18095152 | Breast cancer risk and the BRCA1 interacting protein CTIP. | Breast Cancer Res Treat | 2008 Nov | Gorringe KL | - |
25047474 | Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative. | Ann Surg Oncol | 2014 Oct | Brannon Traxler L | doi: 10.1245/s10434-014-3921-1 |
25821000 | Risk-reducing mastectomy for BRCA gene mutation carriers. | Ann Surg Oncol | 2015 Sep | Euhus DM | doi: 10.1245/s10434-015-4537-9 |
19140568 | Is there any relationship between BRCA1 gene mutation and pancreatic cancer development? | Pol Arch Med Wewn | 2008 Nov | Lawniczak M | - |
20134318 | Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer. | Ann Surg | 2010 Mar | Kaas R | doi: 10.1097/SLA.0b013e3181c3c36d. |
26219241 | Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer. | Ann Surg Oncol | 2015 Oct | Kapoor NS | doi: 10.1245/s10434-015-4754-2 |
25092866 | BRCA1 pathway function in basal-like breast cancer cells. | Mol Cell Biol | 2014 Oct | Hill SJ | doi: 10.1128/MCB.01646-13 |
19885732 | Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. | Breast Cancer Res Treat | 2010 Jan | Domchek SM | doi: 10.1007/s10549-009-0611-y. |
24026861 | BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC. | Breast Cancer Res Treat | 2013 Sep | Ignatov T | doi: 10.1007/s10549-013-2693-9 |
21191178 | Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk. | Cell Cycle | 2011 Jan 1 | Pelletier C | - |
12920090 | BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland. | J Med Genet | 2003 Aug | Ikonen T | - |
25716084 | The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer. | Breast Cancer Res Treat | 2015 Apr | Villarreal-Garza C | doi: 10.1007/s10549-015-3312-8 |
22274685 | Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. | JAMA | 2012 Jan 25 | Bolton KL | doi: 10.1001/jama.2012.20. |
26740498 | Poor response to platinum-based chemotherapy is associated with KRAS mutation and concomitant low expression of BRAC1 and TYMS in NSCLC. | J Int Med Res | 2016 Feb | Zhou H | doi: 10.1177/0300060515607383 |
22426855 | BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer. | Stem Cell Rev | 2012 Sep | Buckley NE | doi: 10.1007/s12015-012-9354-y. |
16996204 | BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area. | Cancer Lett | 2007 Apr 18 | Eachkoti R | - |
24698998 | DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. | PLoS Genet | 2014 Apr 3 | Osorio A | doi: 10.1371/journal.pgen.1004256 |
21404118 | A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer. | Fam Cancer | 2011 Jun | Kwong A | doi: 10.1007/s10689-011-9429-y. |
16261400 | Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. | Breast Cancer Res Treat | 2006 Jan | Gallardo M | - |
20388772 | Immunohistochemical expression of BRCA1 and lethal prostate cancer. | Cancer Res | 2010 Apr 15 | Fiorentino M | doi: 10.1158/0008-5472.CAN-09-4100 |
16912212 | Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. | Cancer Res | 2006 Aug 15 | Malone KE | - |
20579331 | Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection. | J Exp Clin Cancer Res | 2010 Jun 25 | Ibrahim SS | doi: 10.1186/1756-9966-29-82. |
21920589 | BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer. | Gynecol Oncol | 2011 Dec | Carser JE | doi: 10.1016/j.ygyno.2011.08.017 |
21918854 | BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients. | Fam Cancer | 2012 Mar | Keshavarzi F | doi: 10.1007/s10689-011-9477-3. |
17585057 | Common variation in the BRCA1 gene and prostate cancer risk. | Cancer Epidemiol Biomarkers Prev | 2007 Jul | Douglas JA | - |
12442274 | BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. | Hum Mutat | 2002 Dec | Zhi X | - |
17420720 | Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation. | Oncogene | 2007 Sep 13 | Jeng YM | - |
20418484 | Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. | Hum Mol Genet | 2010 Jul 15 | Wang X | doi: 10.1093/hmg/ddq174 |
21603983 | Cancer worry among Norwegian male BRCA1/2 mutation carriers. | Fam Cancer | 2011 Sep | Strmsvik N | doi: 10.1007/s10689-011-9456-8. |
25339023 | Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer. | Asian Pac J Cancer Prev | 2014 | Erturk E | - |
17972172 | Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. | Breast Cancer Res Treat | 2008 May | Breast Cancer Family Registry | - |
25082516 | Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study. | Breast Cancer Res Treat | 2014 Aug | Giannakeas V | doi: 10.1007/s10549-014-3063-y |
15365993 | BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. | Hum Mutat | 2004 Oct | Seo JH | - |
17661168 | BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. | Breast Cancer Res Treat | 2008 Jul | Falchetti M | - |
16905680 | Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. | J Med Genet | 2007 Feb | Simard J | - |
23803067 | mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer. | Asian Pac J Cancer Prev | 2013 | Han Y | - |
22072393 | Gene-gene interactions in breast cancer susceptibility. | Hum Mol Genet | 2012 Feb 15 | Turnbull C | doi: 10.1093/hmg/ddr525 |
23447579 | TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness. | Cancer Res | 2013 May 1 | Shan J | doi: 10.1158/0008-5472.CAN-12-4313 |
23992000 | Identification of germline BRCA1 mutations among breast cancer families in Northeastern Iran. | Asian Pac J Cancer Prev | 2013 | Kooshyar MM | - |
22032289 | BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1. | Biochem J | 2012 Feb 1 | Dohrn L | doi: 10.1042/BJ20110314. |
25792249 | Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. | Fertil Steril | 2015 May | Perri T | doi: 10.1016/j.fertnstert.2015.02.011 |
18844490 | New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia. | Clin Chem Lab Med | 2008 | Cvok ML | doi: 10.1515/CCLM.2008.307. |
26239694 | Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis. | Fam Cancer | 2015 Dec | Basu NN | doi: 10.1007/s10689-015-9825-9. |
17257844 | BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. | Breast | 2007 Jun | Musolino A | - |
19865540 | Functional analysis of familial Asp67Glu and Thr1051Ser BRCA1 mutations in breast/ovarian carcinogenesis. | Int J Mol Sci | 2009 Sep 24 | Pongsavee M | doi: 10.3390/ijms10094187. |
19669600 | Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population. | Fam Cancer | 2009 | Seong MW | doi: 10.1007/s10689-009-9279-z |
18950515 | Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers. | BMC Cancer | 2008 Oct 25 | Toyama T | doi: 10.1186/1471-2407-8-309. |
26299336 | How medical choices influence quality of life of women carrying a BRCA mutation. | Crit Rev Oncol Hematol | 2015 Dec | Harmsen MG | doi: 10.1016/j.critrevonc.2015.07.010 |
22889855 | BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. | J Med Genet | 2012 Aug | Spurdle AB | - |
23958087 | Analysis of several BRCA1 and BRCA2 mutations in a hospital-based series of unselected breast cancer cases. | Chirurgia (Bucur) | 2013 Jul-Aug | Burco T | - |
15983021 | Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. | J Med Genet | 2006 Feb | Haffty BG | - |
16724273 | among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation. | J Genet Couns | 2006 Jun | Kenen R | - |
12112655 | BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases. | Hum Mutat | 2002 Jul | Yazici H | - |
22691290 | Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion. | BMC Cancer | 2012 Jun 12 | Silva AG | doi: 10.1186/1471-2407-12-237. |
17051349 | Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred. | Fam Cancer | 2007 | Vogl FD | - |
12698198 | BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. | Br J Cancer | 2003 Apr 22 | Tassone P | - |
21666281 | Mutations in the BRCT binding site of BRCA1 result in hyper-recombination. | Aging (Albany NY) | 2011 May | Dever SM | - |
12237282 | Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. | J Natl Cancer Inst | 2002 Sep 18 | Brose MS | - |
22736296 | Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences. | Cancer | 2012 Dec 15 | Hurley K | doi: 10.1002/cncr.27695 |
20451485 | Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer. | Cancer Epidemiol | 2010 Aug | Sharifah NA | doi: 10.1016/j.canep.2010.04.010 |
19887602 | Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. | Cancer Res | 2009 Nov 15 | Ueki T | doi: 10.1158/0008-5472.CAN-09-1809 |
23767878 | BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families. | BMC Med Genet | 2013 Jun 14 | Berzina D | doi: 10.1186/1471-2350-14-61. |
17850627 | Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families. | Clin Genet | 2007 Oct | Hartikainen JM | - |
19729830 | Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue. | Cancer Biomark | 2009 | Bhavani V | doi: 10.3233/CBM-2009-0105. |
19858402 | Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. | J Clin Oncol | 2009 Dec 10 | Graeser MK | doi: 10.1200/JCO.2008.19.9430 |
22110403 | Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. | PLoS Biol | 2011 Nov | Maxwell CA | doi: 10.1371/journal.pbio.1001199 |
17453335 | Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients. | Breast Cancer Res Treat | 2008 Feb | Konstantopoulou I | - |
25066186 | Identification of a recurrent BRCA1 exon 21-22 genomic rearrangement in Malay breast cancer patients. | Clin Genet | 2015 Apr | Hasmad HN | doi: 10.1111/cge.12451 |
23278966 | cDNA analysis of the BRCA1 unclassified variant c.5194-12G>A. | Clin Genet | 2013 Nov | Wong-Brown MW | doi: 10.1111/cge.12052 |
27272846 | Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes. | Anticancer Res | 2016 Jun | Kolben T | - |
24312913 | A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. | Biomed Res Int | 2013 | Karami F | doi: 10.1155/2013/928562 |
20338046 | DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. | Mol Cancer | 2010 Mar 25 | Dejeux E | doi: 10.1186/1476-4598-9-68. |
22946335 | [Prevalence of mutations BRCA1 5382insC, and CHEK2 1100delC in the population of Siberian region]. | Genetika | 2012 Jun | Chasovnikova OB | - |
26195437 | Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer. | Clin Breast Cancer | 2015 Dec | Yamashita N | doi: 10.1016/j.clbc.2015.06.009 |
24443257 | ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy. | Tumour Biol | 2014 May | Qin X | doi: 10.1007/s13277-014-1615-8 |
26083025 | Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers. | PLoS One | 2015 Jun 17 | Domagala P | doi: 10.1371/journal.pone.0130393 |
12668603 | Roles of BRCA1 in DNA damage repair: a link between development and cancer. | Hum Mol Genet | 2003 Apr 1 | Deng CX | - |
12442273 | BRCA1 and BRCA2 in Indian breast cancer patients. | Hum Mutat | 2002 Dec | Saxena S | - |
18813953 | Association of loss of BRCA1 expression with centrosome aberration in human breast cancer. | J Cancer Res Clin Oncol | 2009 Mar | Shimomura A | doi: 10.1007/s00432-008-0472-5 |
20135344 | Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. | Breast Cancer Res Treat | 2010 Sep | Reding KW | doi: 10.1007/s10549-010-0769-3 |
26637364 | High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer. | Mol Cancer Ther | 2016 Jan | Schouten PC | doi: 10.1158/1535-7163.MCT-15-0470 |
26902145 | BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1. | Sci Rep | 2016 Feb 23 | Zhang W | doi: 10.1038/srep22034. |
17063264 | Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. | Breast Cancer Res Treat | 2007 Sep | Jakubowska A | - |
22093627 | [EGFR gene copy number, ERCC1 and BRCA1 protein expression and their relationship in non-small cell lung cancer]. | Zhonghua Zhong Liu Za Zhi | 2011 Jul | Deng QH | - |
17080309 | High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. | Breast Cancer Res Treat | 2007 Jun | Torres D | - |
22685544 | BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells. | PLoS One | 2012 | Karve TM | doi: 10.1371/journal.pone.0037697 |
22476849 | Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition. | Breast Cancer Res Treat | 2012 Jun | Rouleau E | doi: 10.1007/s10549-012-2009-5 |
22970155 | Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. | PLoS One | 2012 | Kwong A | doi: 10.1371/journal.pone.0043994 |
24140203 | The sex hormone system in carriers of BRCA1/2 mutations: a case-control study. | Lancet Oncol | 2013 Nov | Widschwendter M | doi: 10.1016/S1470-2045(13)70448-0 |
22262156 | Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. | Obesity (Silver Spring) | 2012 Jun | McGee J | doi: 10.1038/oby.2011.394 |
19383352 | Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene. | Mol Oncol | 2008 Dec | Bartkova J | doi: 10.1016/j.molonc.2008.09.007 |
26852015 | Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer. | BMC Cancer | 2016 Feb 6 | Cao WM | doi: 10.1186/s12885-016-2107-6. |
24297685 | Detection of a novel mutation in exon 20 of the BRCA1 gene. | Cell Mol Biol Lett | 2013 Dec | Chakraborty A | doi: 10.2478/s11658-013-0110-3 |
17645508 | Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series. | Int J Gynecol Cancer | 2008 May-Jun | Kwon JS | - |
23320992 | Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics. | Breast J | 2013 Mar-Apr | Pal T | doi: 10.1111/tbj.12083 |
17599361 | Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. | Life Sci | 2007 Jul 4 | Mirza S | - |
20730487 | Body weight and risk of breast cancer in BRCA1/2 mutation carriers. | Breast Cancer Res Treat | 2011 Feb | Manders P | doi: 10.1007/s10549-010-1120-8 |
27039803 | BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia. | Asian Pac J Cancer Prev | 2016 | Mundhofir FE | - |
16773440 | Premature menopause in patients with BRCA1 gene mutation. | Breast Cancer Res Treat | 2006 Nov | Rzepka-G??rska I | - |
12181777 | Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. | Am J Hum Genet | 2002 Sep | Liede A | - |
25257187 | Salivary gland cancer in BRCA-positive families: a retrospective review. | JAMA Otolaryngol Head Neck Surg | 2014 Dec | Shen TK | doi: 10.1001/jamaoto.2014.1998. |
27244682 | BRCA1 and BRCA2 Testing Among Young Breast Cancer Survivors. | JAMA Oncol | 2016 May 1 | Kehl KL | doi: 10.1001/jamaoncol.2016.0976. |
16830385 | Genetic instability of BRCA1 gene at locus D17S855 is related to clinicopathological behaviors of gastric cancer from Chinese population. | World J Gastroenterol | 2006 Jul 14 | Chen XR | - |
22923021 | Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families. | Int J Oncol | 2012 Nov | Novakovi S | doi: 10.3892/ijo.2012.1595 |
23462720 | BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study. | Br J Cancer | 2013 Apr 2 | Lesnock JL | doi: 10.1038/bjc.2013.70 |
24306927 | Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. | Cell Oncol (Dordr) | 2014 Feb | Yiannakopoulou E | doi: 10.1007/s13402-013-0158-0 |
21391735 | BRCA1/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer. | Neoplasma | 2011 | Cvelbar M | - |
19200354 | A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history. | Breast Cancer Res | 2009 | G??mez Garc??a EB | doi: 10.1186/bcr2223 |
16949048 | Identification of BRCA1 and BRCA2 mutations from Korean breast cancer patients using denaturing HPLC. | Biochem Biophys Res Commun | 2006 Oct 20 | Kim BY | - |
23787073 | Genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer susceptibility among Chinese Han women. | Cancer Epidemiol | 2013 Oct | Zheng L | doi: 10.1016/j.canep.2013.04.018 |
23405268 | Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer. | PLoS One | 2013 | Hsu NC | doi: 10.1371/journal.pone.0056256 |
22576580 | Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study. | Cancer Causes Control | 2012 Jul | Kotsopoulos J | doi: 10.1007/s10552-012-9975-0 |
22009639 | Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ. | Cancer | 2012 Mar 15 | Bayraktar S | doi: 10.1002/cncr.26428 |
17220212 | Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. | J Med Genet | 2007 Jun | Jakubowska A | - |
12427738 | Structural consequences of a cancer-causing BRCA1-BRCT missense mutation. | J Biol Chem | 2003 Jan 24 | Williams RS | - |
17902052 | G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. | Breast Cancer Res Treat | 2008 Jul | Anagnostopoulos T | - |
22586318 | Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers. | Cancer Discov | 2011 Jun | Balmaa J | doi: 10.1158/2159-8274.CD-11-0048 |
19360465 | BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. | Breast Cancer Res Treat | 2010 Jan | Jakubowska A | doi: 10.1007/s10549-009-0390-5 |
19364506 | BRCA1 down-regulates cellular levels of reactive oxygen species. | FEBS Lett | 2009 May 6 | Saha T | doi: 10.1016/j.febslet.2009.04.005 |
20215531 | Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. | Clin Cancer Res | 2010 Apr 1 | Gallagher DJ | doi: 10.1158/1078-0432.CCR-09-2871 |
25783183 | Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer. | Breast Cancer Res Treat | 2015 Apr | Zhu X | doi: 10.1007/s10549-015-3338-y |
18957670 | Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. | J Natl Cancer Inst | 2008 Nov 5 | Lose F | doi: 10.1093/jnci/djn345 |
21276604 | Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. | Gynecol Oncol | 2011 May 1 | Lacour RA | doi: 10.1016/j.ygyno.2010.12.354 |
17635951 | Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. | J Clin Oncol | 2007 Sep 1 | Brohet RM | - |
12237273 | Cancer risks in BRCA1 carriers: time for the next generation of studies. | J Natl Cancer Inst | 2002 Sep 18 | Gruber SB | - |
17039264 | Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study. | Breast Cancer Res Treat | 2007 Jun | Soucek P | - |
11916966 | A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. | J Biol Chem | 2002 Jun 7 | Li H | - |
18936947 | The effect of symptom duration in epithelial ovarian cancer on prognostic factors. | Arch Gynecol Obstet | 2009 Jun | Menczer J | doi: 10.1007/s00404-008-0814-1 |
24477976 | Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status. | Breast Cancer Res Treat | 2014 Feb | Nilsson MP | doi: 10.1007/s10549-014-2842-9 |
23954390 | Co-occurrence of multiple sclerosis and cancer in a BRCA1 positive family. | Eur J Med Genet | 2013 Oct | Holzmann C | doi: 10.1016/j.ejmg.2013.07.006 |
25980896 | Psychological distress related to BRCA testing in ovarian cancer patients. | Fam Cancer | 2015 Dec | Bjrnslett M | doi: 10.1007/s10689-015-9811-2. |
26402875 | Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations. | Int J Gynecol Cancer | 2015 Oct | Choi MC | doi: 10.1097/IGC.0000000000000529. |
26949839 | CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in healthy tissue. | Epigenetics | 2016 | Etzold A | doi: 10.1080/15592294.2016.1140295 |
16026807 | BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. | Mutat Res | 2005 Oct 15 | Tommasi S | - |
23262210 | Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing. | Gynecol Oncol | 2013 Mar | Norquist BM | doi: 10.1016/j.ygyno.2012.12.015 |
26439132 | BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer. | Cancer | 2016 Jan 1 | Sakamoto I | doi: 10.1002/cncr.29707 |
21984204 | Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2012 Feb | Bernholtz S | doi: 10.1007/s10549-011-1807-5 |
24947589 | First recurrent large genomic rearrangement in the BRCA1 gene found in Poland. | Cancer Epidemiol | 2014 Aug | Rudnicka H | doi: 10.1016/j.canep.2014.05.010 |
18034184 | Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. | Nat Rev Cancer | 2007 Dec | Fackenthal JD | - |
21427728 | Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. | Br J Cancer | 2011 Apr 12 | Osorio A | doi: 10.1038/bjc.2011.91 |
21557934 | Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controls. | Clin Chim Acta | 2011 Jul 15 | Bosviel R | doi: 10.1016/j.cca.2011.04.027 |
18257128 | BRCA1/2 associated hereditary breast cancer. | J Zhejiang Univ Sci B | 2008 Feb | Teng LS | doi: 10.1631/jzus.B0710617. |
25892146 | BRCA1 and BRCA2 mutation type associated with cancer risk. | Lancet Oncol | 2015 May | Burki TK | doi: 10.1016/S1470-2045(15)70187-7 |
22655046 | Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer. | PLoS One | 2012 | Vaca-Paniagua F | doi: 10.1371/journal.pone.0037432 |
22684231 | BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. | Dis Markers | 2012 | Cherbal F | doi: 10.3233/DMA-2012-0893. |
20882403 | BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. | Breast Cancer Res Treat | 2011 Aug | Iwamoto T | doi: 10.1007/s10549-010-1188-1 |
26028024 | Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations. | Oncogene | 2016 Mar 10 | Golmard L | doi: 10.1038/onc.2015.181 |
25808098 | Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. | Ann Surg Oncol | 2015 Sep | De Felice F | doi: 10.1245/s10434-015-4532-1 |
21161372 | Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status. | Breast Cancer Res Treat | 2011 Jun | Figueiredo JC | doi: 10.1007/s10549-010-1285-1 |
25756400 | Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications. | Int J Gynecol Cancer | 2015 May | Casey MJ | doi: 10.1097/IGC.0000000000000402. |
19035463 | Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? | Int J Cancer | 2009 Feb 15 | van der Velde NM | doi: 10.1002/ijc.24038. |
13679996 | BRCA1 and p53: compensatory roles in DNA repair. | J Mol Med (Berl) | 2003 Nov | Hartman AR | - |
25526195 | Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer. | Genet Mol Res | 2014 Dec 18 | Cao WM | doi: 10.4238/2014.December.18.16. |
21649643 | Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes. | Clin Genet | 2011 Jul | Zhang L | doi: 10.1111/j.1399-0004.2011.01691.x. |
18694767 | Molecular and in silico analysis of BRCA1 and BRCA2 variants. | Mutat Res | 2008 Sep 26 | Tommasi S | doi: 10.1016/j.mrfmmm.2008.07.005 |
19370414 | Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2010 Jan | Milne RL | doi: 10.1007/s10549-009-0394-1 |
24884718 | Genome instability in blood cells of a BRCA1+ breast cancer family. | BMC Cancer | 2014 May 19 | Xiao F | doi: 10.1186/1471-2407-14-342. |
19123044 | Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin. | Fam Cancer | 2009 | Santos C | doi: 10.1007/s10689-008-9229-1 |
25503195 | Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis. | Oncology | 2015 | Saam J | doi: 10.1159/000368836 |
25085752 | Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes. | Breast Cancer Res Treat | 2014 Aug | Pruss D | doi: 10.1007/s10549-014-3065-9 |
12474142 | Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. | Am J Hum Genet | 2003 Jan | Edwards SM | - |
24700448 | Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer. | Int J Cancer | 2014 Nov 15 | Kast K | doi: 10.1002/ijc.28875 |
19499246 | BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients. | J Cancer Res Clin Oncol | 2009 Nov | Lim MC | doi: 10.1007/s00432-009-0607-3 |
22962264 | Targeting BRCA1 localization to augment breast tumor sensitivity to poly(ADP-Ribose) polymerase inhibition. | Cancer Res | 2012 Nov 1 | Yang ES | doi: 10.1158/0008-5472.CAN-12-0934 |
19491284 | Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. | Ann Oncol | 2009 Oct | Haffty BG | doi: 10.1093/annonc/mdp051 |
26299666 | Differential Gene Expression of BRCA1,ERBB2 and TP53 biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer. | Anticancer Agents Med Chem | 2016 | Zghair AN | - |
23292835 | Prognostic significance of BRCA1 expression in gastric cancer. | Med Oncol | 2013 Mar | Chen W | doi: 10.1007/s12032-012-0423-5 |
21537840 | Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women. | Int J Oncol | 2011 Jul | Al-Moghrabi N | doi: 10.3892/ijo.2011.1021 |
21424757 | Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer. | Fam Cancer | 2011 Sep | Kiely BE | doi: 10.1007/s10689-011-9435-0. |
16450717 | [Prophylactic oophorectomy among carriers of BRCA1/2 mutations--demographic and pathologic data]. | Harefuah | 2006 Jan | Daum H | - |
23640417 | Screening for genomic rearrangements at BRCA1 locus in Iranian women with breast cancer using multiplex ligation-dependent probe amplification. | J Genet | 2013 Apr | Yassaee VR | - |
12237285 | Inactivation of BRCA1 and BRCA2 in ovarian cancer. | J Natl Cancer Inst | 2002 Sep 18 | Hilton JL | - |
18334730 | Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. | Cancer Biomark | 2008 | Troudi W | - |
25711630 | High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation. | Med Oncol | 2015 Apr | Moiseyenko VM | doi: 10.1007/s12032-015-0514-1 |
20940403 | BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. | Cancer Res | 2010 Nov 1 | Chock KL | doi: 10.1158/0008-5472.CAN-10-1352 |
25868867 | Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. | Breast Cancer Res Treat | 2015 May | Cragun D | doi: 10.1007/s10549-015-3374-7 |
16718381 | Analysis of loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers. | Mol Cell Biochem | 2006 Jul | Dinesh KP | - |
24729269 | BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan. | Fam Cancer | 2014 Sep | Biunno I | doi: 10.1007/s10689-014-9717-4. |
22744714 | DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. | Tumour Biol | 2012 Dec | Sharma G | doi: 10.1007/s13277-012-0443-y |
20505321 | Basal-like breast cancer displays distinct patterns of promoter methylation. | Cancer Biol Ther | 2010 Jun 15 | Lee JS | - |
22768030 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. | PLoS One | 2012 | Kirchhoff T | doi: 10.1371/journal.pone.0035706 |
25987085 | Consanguinity Protecting Effect Against Breast Cancer among Tunisian Women: Analysis of BRCA1 Haplotypes. | Asian Pac J Cancer Prev | 2015 | Medimegh I | - |
25520075 | BRCA1 promoter hypermethylation signature for early detection of breast cancer in the Vietnamese population. | Asian Pac J Cancer Prev | 2014 | Truong PK | - |
22752604 | BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. | Med Oncol | 2012 Dec | Juwle A | doi: 10.1007/s12032-012-0294-9 |
18501021 | Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families. | BMC Cancer | 2008 May 26 | Pylks K | doi: 10.1186/1471-2407-8-146. |
19079346 | Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. | Oncogene | 2009 Feb 12 | Gonzalez ME | doi: 10.1038/onc.2008.433 |
26026974 | BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study. | Fam Cancer | 2015 Dec | de Juan I | doi: 10.1007/s10689-015-9814-z. |
18375895 | Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators. | J Clin Oncol | 2008 Apr 1 | Spurdle AB | doi: 10.1200/JCO.2007.13.2779. |
24479546 | RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families. | BMC Med Genomics | 2014 Jan 31 | Larsen MJ | doi: 10.1186/1755-8794-7-9. |
26181175 | Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. | JAMA Oncol | 2015 Jun | Metcalfe K | doi: 10.1001/jamaoncol.2015.0658. |
15285306 | The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives. | Eur J Gynaecol Oncol | 2004 | Skasko E | - |
19619314 | A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population. | BMC Cancer | 2009 Jul 20 | Palomba G | doi: 10.1186/1471-2407-9-245. |
18000219 | Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. | J Natl Cancer Inst | 2007 Nov 21 | Hosey AM | - |
11793480 | BRCA1 and BRCA2 mutations in Russian familial breast cancer. | Hum Mutat | 2002 Feb | Tereschenko IV | - |
25454609 | Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer. | Eur Urol | 2015 Aug | Castro E | doi: 10.1016/j.eururo.2014.10.022 |
25136623 | BRCA-associated ovarian cancer: from molecular genetics to risk management. | Biomed Res Int | 2014 | Girolimetti G | doi: 10.1155/2014/787143 |
15917310 | BRCA1 and BRCA2 as ovarian cancer susceptibility genes. | Carcinogenesis | 2005 Oct | Sowter HM | - |
23867999 | Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. | Br J Cancer | 2013 Aug 20 | Moon DH | doi: 10.1038/bjc.2013.389 |
19405875 | The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor. | Genet Test Mol Biomarkers | 2009 Jun | Pongsavee M | doi: 10.1089/gtmb.2008.0127. |
21484799 | Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriers. | Int J Cancer | 2012 Mar 15 | Dick MG | doi: 10.1002/ijc.26134 |
18712473 | The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts. | Breast Cancer Res Treat | 2009 Sep | Guti??rrez-Enr??quez S | doi: 10.1007/s10549-008-0154-7 |
26085381 | BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review. | Fam Cancer | 2015 Dec | Spinelli C | doi: 10.1007/s10689-015-9819-7. |
19214744 | CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. | Breast Cancer Res Treat | 2010 Jan | Palanca Suela S | doi: 10.1007/s10549-009-0316-2 |
16940443 | BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells. | J Clin Endocrinol Metab | 2006 Nov | Lu M | - |
12237897 | Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. | Int J Cancer | 2002 Oct 20 | Mller P | - |
27068824 | Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population. | Breast Cancer | 2017 Mar | Parvin S | doi: 10.1007/s12282-016-0692-5 |
22179631 | Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer. | Ann Surg Oncol | 2012 May | Okada S | doi: 10.1245/s10434-011-2166-5 |
25376744 | Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer. | Breast Cancer Res Treat | 2014 Dec | Gupta S | doi: 10.1007/s10549-014-3179-0 |
18175216 | The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. | Breast Cancer Res Treat | 2008 Dec | Choi DH | doi: 10.1007/s10549-007-9878-z |
19876733 | The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2010 Jun | Jakubowska A | doi: 10.1007/s10549-009-0595-7 |
24191908 | BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer. | BMC Cancer | 2013 Nov 5 | Jacot W | doi: 10.1186/1471-2407-13-523. |
20309627 | Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. | Breast Cancer Res Treat | 2010 Nov | Moorman PG | doi: 10.1007/s10549-010-0842-y |
19584272 | Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. | Cancer Res | 2009 Jul 15 | Rebbeck TR | doi: 10.1158/0008-5472.CAN-09-0625 |
23039163 | Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers. | BMC Cancer | 2012 Oct 5 | Bjrnslett M | doi: 10.1186/1471-2407-12-454. |
12505256 | Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families. | Cancer Genet Cytogenet | 2002 Oct 15 | Balz V | - |
24752797 | Development of serous ovarian cancer is associated with the expression of homologous recombination pathway proteins. | Pathol Oncol Res | 2014 Oct | Ye Q | doi: 10.1007/s12253-014-9776-8 |
24285858 | Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. | J Med Genet | 2014 Feb | Brohet RM | doi: 10.1136/jmedgenet-2013-101974 |
18165636 | Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer. | J Clin Oncol | 2008 Jan 1 | Chetrit A | doi: 10.1200/JCO.2007.11.6905. |
21135055 | An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients. | Ann Oncol | 2011 Jul | Vollebergh MA | doi: 10.1093/annonc/mdq624 |
25445393 | BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer. | Gene | 2015 Feb 10 | Erturk E | doi: 10.1016/j.gene.2014.11.047 |
23879077 | Screening for BRCA1 large genomic rearrangements in female Egyptian hereditary breast cancer patients. | East Mediterr Health J | 2013 Mar | Hagag E | - |
26171949 | Occurrence of a non deleterious gene conversion event in the BRCA1 gene. | Genes Chromosomes Cancer | 2015 Oct | Tessereau C | doi: 10.1002/gcc.22278 |
24342616 | HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway. | Biochem Biophys Res Commun | 2014 Feb 14 | Wang X | doi: 10.1016/j.bbrc.2013.12.053 |
23615136 | Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care. | Oncol Nurs Forum | 2013 May 1 | Mahon SM | doi: 10.1188/13.ONF.220-222. |
18340530 | BRCA1 2080insA mutation in familial breast cancer. | Breast Cancer Res Treat | 2009 Feb | Alansari AS | doi: 10.1007/s10549-008-9961-0 |
19615284 | [Correlation of BRCA1 and APC aberrant methylation with the response to anthracycline-based neoadjuvant chemotherapy in primary breast cancer]. | Zhonghua Zhong Liu Za Zhi | 2009 Apr | Yuan P | - |
19656774 | Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. | Hum Mol Genet | 2009 Nov 15 | Antoniou AC | doi: 10.1093/hmg/ddp372 |
19802015 | Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. | Oncogene | 2010 Jan 7 | Wolf I | doi: 10.1038/onc.2009.301 |
16724249 | Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patients. | Fam Cancer | 2006 | Ellis D | - |
17406974 | BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer. | Breast Cancer Res Treat | 2007 Sep | Ali AB | - |
23918944 | Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. | J Clin Oncol | 2013 Sep 1 | Phillips KA | doi: 10.1200/JCO.2012.47.8313 |
23740344 | International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. | Ann Surg Oncol | 2013 Nov | Semple J | doi: 10.1245/s10434-013-3040-4 |
25311111 | Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2014 Nov | Chai X | doi: 10.1007/s10549-014-3134-0 |
19268590 | PALB2 links BRCA1 and BRCA2 in the DNA-damage response. | Curr Biol | 2009 Mar 24 | Zhang F | doi: 10.1016/j.cub.2009.02.018 |
25195694 | BRCA1 and BRCA2 mutations and the risk for colorectal cancer. | Clin Genet | 2015 May | Sopik V | doi: 10.1111/cge.12497 |
21394826 | Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary. | Hum Mutat | 2011 Jun | Whiley PJ | doi: 10.1002/humu.21495 |
17253935 | Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer. | Genet Test | 2006 Winter | Chen Y | - |
25194442 | Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects. | Biomed Pharmacother | 2014 Sep | Qin TT | doi: 10.1016/j.biopha.2014.08.006 |
19383375 | The contribution of BRCA1 and BRCA2 to ovarian cancer. | Mol Oncol | 2009 Apr | Ramus SJ | doi: 10.1016/j.molonc.2009.02.001 |
25927284 | BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study. | Cell Cycle | 2015 | Gau DM | doi: 10.1080/15384101.2015.1036203. |
22488590 | Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells. | Mol Carcinog | 2013 Sep | Yi YW | doi: 10.1002/mc.21905 |
19098453 | BRCA1 mutations contribute to cell motility and invasion by affecting its main regulators. | Cell Cycle | 2008 Dec | Yasmeen A | - |
22167321 | Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NF??B pathway. | Breast Cancer Res Treat | 2012 Jul | Tanic M | doi: 10.1007/s10549-011-1905-4 |
18097605 | BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. | Oncol Rep | 2008 Jan | Ratajska M | - |
26029931 | Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways. | PLoS One | 2015 Jun 1 | Heublein S | doi: 10.1371/journal.pone.0127072 |
18413372 | Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers. | J Med Genet | 2009 Sep | Evans DG | doi: 10.1136/jmg.2008.058248 |
14729053 | Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain. | Exp Cell Res | 2004 Feb 1 | Rodriguez JA | - |
28407998 | A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer. | Value Health | 2017 Apr | Eccleston A | doi: 10.1016/j.jval.2017.01.004 |
27928164 | Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer. | J Hum Genet | 2017 Mar | Antonucci I | doi: 10.1038/jhg.2016.138 |
28120435 | Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer. | Int J Cancer | 2017 May 1 | Halpern N | doi: 10.1002/ijc.30616 |
27430397 | Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience. | Gynecol Oncol | 2016 Oct | Harmsen MG | doi: 10.1016/j.ygyno.2016.07.104 |
27362900 | The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection. | Int J Gynecol Pathol | 2017 Mar | Hjortkjr M | doi: 10.1097/PGP.0000000000000310. |
28184945 | First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report. | Oncol Rep | 2017 Mar | Meynard G | doi: 10.3892/or.2017.5422 |
28183138 | Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer. | Br J Cancer | 2017 Mar 14 | Golan T | doi: 10.1038/bjc.2017.19 |
27693788 | Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling. | Biochem Biophys Res Commun | 2016 Oct 28 | Xu X | doi: 10.1016/j.bbrc.2016.09.087 |
26926928 | Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment. | Prostate Cancer Prostatic Dis | 2016 Jun | Sanchez A | doi: 10.1038/pcan.2016.4 |
26541979 | Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients. | Gynecol Oncol | 2016 May | Hasmad HN | doi: 10.1016/j.ygyno.2015.11.001 |
27272763 | Association Between BRCA Status and P53 Status in Breast Cancer: A Meta-Analysis. | Med Sci Monit | 2016 Jun 8 | Peng L | - |
27798111 | The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer. | Hum Mol Genet | 2016 Dec 15 | Dickson KA | doi: 10.1093/hmg/ddw362. |
27239795 | Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection. | Nat Struct Mol Biol | 2016 Jul | Densham RM | doi: 10.1038/nsmb.3236 |
27225819 | BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report. | Genes Chromosomes Cancer | 2016 Oct | Pilato B | doi: 10.1002/gcc.22383 |
28247011 | Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mutation carriers with advanced solid tumors or in subjects with high grade serous ovarian, primary peritoneal or fallopian tube cancer. | Cancer Chemother Pharmacol | 2017 Mar | Mittapalli RK | doi: 10.1007/s00280-017-3262-4 |
27623744 | The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania. | Clin Genet | 2017 Feb | Menkiszak J | doi: 10.1111/cge.12865 |
28024868 | Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer. | Gastroenterology | 2017 Apr | Sahasrabudhe R | doi: 10.1053/j.gastro.2016.12.010 |
27484786 | Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization. | Cell Cycle | 2016 Oct 17 | Lodovichi S | doi: 10.1080/15384101.2016.1215389 |
28212807 | Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing. | Cancer Genet | 2017 Jan | Riahi A | doi: 10.1016/j.cancergen.2016.11.002 |
26785832 | Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study. | Eur J Hum Genet | 2016 Aug | Garcia AI | doi: 10.1038/ejhg.2015.284 |
27197267 | The BRCA1-??11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin. | Cancer Res | 2016 May 1 | Wang Y | doi: 10.1158/0008-5472.CAN-16-0186. |
28079255 | Moonlighting at replication forks - a new life for homologous recombination proteins BRCA1, BRCA2 and RAD51. | FEBS Lett | 2017 Apr | Kolinjivadi AM | doi: 10.1002/1873-3468.12556 |
28551646 | Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-BRCA-associated Entity. | Anticancer Res | 2017 Jun | Neuhausen SL | - |
26300001 | The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability. | Oncogene | 2016 May 5 | L??ddecke S | doi: 10.1038/onc.2015.290 |
27373334 | BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells. | |